Document:

EXHIBIT 10.8

 

EXECUTION VERSION

 

6 July 2017

 

 

Santo Holding (Deutschland) GmbH

(as Lender)

 

 

and

 

 

EQT Avatar Topco, Inc.

(as Borrower)

 

 

 

 

 

 

LOAN AGREEMENT

 

related to

 

the purchase of Certara
Holdco, Inc. (f/k/a Arsenal MBDD Holdco, Inc.)

 

 

 

 

     

     

    

 

TABLE OF CONTENTS

 

	 	Clause	 	Page
		1.	DEFINITIONS AND INTERPRETATION	1
		2.	THE FACILITY	3
		3.	CONDITIONS PRECEDENT	3
		4.	PURPOSE	4
		5.	REPAYMENT	4
		6.	VOLUNTARY
PREPAYMENT	4
		7.	CHANGE
OF CONTROL	4
		8.	INTEREST	4
		9.	OID FEE	5
		10.	REPRESENTATIONS	5
		11.	EVENTS
OF DEFAULT	5
		12.	COSTS
AND EXPENSES	6
		13.	PAYMENTS	7
		14.	FURTHER
ASSURANCE	7
		15.	ENTIRE
AGREEMENT AND REMEDIES	7
		16.	WAIVER
AND VARIATION	8
		17.	INVALIDITY	8
		18.	ASSIGNMENT	8
		19.	NOTICES	8
		20.	COUNTERPARTS	9
		21.	GOVERNING
LAW AND JURISDICTION	9
		22.	TAX
FORMS	9

 

     

     

    

 

THIS AGREEMENT is made on July 6, 2017

 

BETWEEN

 

		(1)	SANTO HOLDING (DEUTSCHLAND) GMBH, a company incorporated in Germany with registered number
[                                  ] and having its registered office at Bergfeldstrasse 9, 83607 Holzkirchen, Germany (the "Lender"); and

 

		(2)	EQT AVATAR TOPCO, INC., a corporation organized under the laws of Delaware (the "Borrower").

 

WHEREAS

 

		(A)	This Agreement is being entered into in connection with the Securities Purchase Agreement to be
entered into between, EQT Avatar Holdings, Inc., Arsenal MBDD Holding, L.P. and Certara Holdco, Inc. (f/k/a Arsenal MBDD
Holdco, Inc.) relating to the acquisition of, directly or indirectly, the capital stock and other equity interests of Certara
Holdco, Inc. (f/k/a Arsenal MBDD Holdco, Inc.), a corporation organized under the laws of Delaware, from the existing
equity holders thereof (the "Acquisition Agreement").

 

		(B)	In accordance with the terms of this Agreement, the Lender wishes to make a loan in an aggregate
initial principal amount equal to up to $110,000,000 (or such lesser amount as the Borrower may request by written notice to the
Lender at least two (2) Business Days prior to the Utilisation Date) (the "Facility Amount") available to
the Borrower.

 

IT IS AGREED THAT

 

		1.	DEFINITIONS AND INTERPRETATION

 

		1.1	In this Agreement:

 

		(a)	"Business Day" means a day (other than a Saturday or Sunday) on which banks are
open for general business in New York, London and Munich.

 

		(b)	"Change of Control" means and shall be deemed to have occurred if EQT, the Lender
and the Related Parties individually or taken as a whole cease to beneficially own and control (directly or indirectly) the majority
of the votes attaching to the shares of the Borrower.

 

		(c)	"Code" means the Internal Revenue Code of 1986, as amended.

 

		(d)	"EQT" means any fund, investment vehicle or managed account arrangement operated
and/or managed and/or advised by any one or more of EQT Services (UK) Limited, EQT Fund Management S.à r.l., CBTJ Financial
Services B.V., EQT Holdings AB, SEP Holdings B.V. or any of their respective Affiliates (each an “EQT member”)
and including, for the avoidance of doubt, the fund known as "EQT VII" (being comprised of EQT VII (No.1) Limited Partnership,
EQT VII (No. 2) Limited Partnership (in each case acting by its manager, EQT Services (UK) Limited (or any successor or replacement
thereof)) and each co-investment scheme, additional or alternative investment vehicle or managed account arrangement established
by any EQT member to invest alongside any of the foregoing in any one or more investments which in each case is operated and/or
managed and/or advised by any EQT member.

 

		(e)	"Event of Default" means any event or circumstance specified as such in Clause
11 (Events of Default).

 

    1 

     

    

 

		(f)	"Facility" means the term loan facility made available under this Agreement as
described in Clause 2 (The Facility).

 

		(g)	"Final Maturity Date" means the eighth anniversary of the Utilisation Date.

 

		(h)	"Interest Payment Date" means:

 

		(i)	each 15 January and 15 July after the Utilisation Date, or

 

		(ii)	any other date agreed between the Borrower and the Lender,

 

provided that the first Interest
Payment Date shall be 15 January 2018 and the final Interest Payment Date shall be the Final Maturity Date.

 

		(i)	"Interest Period" means, in relation to the Loan, each period from (and including)
the previous Interest Payment Date to (but excluding) the next Interest Payment Date, provided that:

 

		(i)	the first Interest Period shall begin on (and include) the Utilisation Date and shall end on (but
exclude) the first Interest Payment Date; and

 

		(ii)	the final Interest Period shall end on (but exclude) the Final Maturity Date.

 

		(j)	"Loan" means the loan made or to be made under the Facility or the principal amount
outstanding for the time being of that loan.

 

		(k)	"Related Party" means, in respect of each of Dr. Andreas Strüngmann
and Dr. Thomas Strüngmann:

 

		(i)	such individual, his parents or spouse and/or any of such individual's, his spouse's, or his parents'
respective direct descendents; and

 

		(ii)	any trust, corporation, partnership, limited liability company or other entity, the beneficiaries,
shareholders, partners, members, owners or persons beneficially holding a 50.1% or more controlling interest of which consists
of any one or more of such individual and/or any such other persons referred to in paragraph (i) above.

 

		(l)	"Utilisation Date" means the date on which the Loan is advanced in accordance
with Clause 2.2 (The Facility).

 

		1.2	In this Agreement, unless the context otherwise requires:

 

		(a)	references to the singular shall include the plural and vice versa;

 

		(b)	references to a "party" means a party to this Agreement and includes its permitted
successors in title, personal representatives and permitted assigns;

 

		(c)	references to a "person" includes any individual, partnership, body corporate,
corporation sole or aggregate, state or agency of a state, and any unincorporated association or organisation, in each case whether
or not having separate legal personality;

 

		(d)	references to "Dollars", "dollars" or “$” mean the lawful
money of the United States of America;

 

    2 

     

    

 

		(e)	references to writing shall include any modes of reproducing words in a legible and non-transitory
form;

 

		(f)	words introduced by the word "other" shall not be given a restrictive meaning
because they are preceded by words referring to a particular class of acts, matters or things;

 

		(g)	general words shall not be given a restrictive meaning because they are followed by words which
are particular examples of the acts, matters or things covered by the general words and the words "includes" and
 "including" shall be construed without limitation; and

 

		(h)	an Event of Default is "continuing" if it has not been remedied or waived.

 

		1.3	The headings and sub-headings in this Agreement are inserted for convenience only and shall not
affect the construction of this Agreement.

 

		1.4	References to this Agreement include this Agreement as amended or varied in accordance with its
terms.

 

		1.5	Where any natural person gives a certificate or other document or otherwise gives a representation
or statement on behalf of any of the parties to this Agreement pursuant to any provision thereof and such certificate or other
document, representation or statement proves to be incorrect, the individual shall incur no personal liability in consequence of
such certificate, other document, representation or statement being incorrect save where such individual acted fraudulently in
giving such certificate, other document, representation or statement (in which case any liability of such individual shall be determined
in accordance with applicable law).

 

		2.	THE FACILITY

 

		2.1	Subject to the terms of this Agreement, the Lender makes available to the Borrower a Dollar term
loan facility in an aggregate amount equal to the Facility Amount.

 

		2.2	Subject only to Clause 3 (Conditions Precedent), the Lender shall advance the Facility Amount
in full (less the OID Fee, as defined in Clause 9 (OID Fee) below) in immediately available funds to such bank account and
on such date as the Borrower may specify on not less than 2 Business Days' notice to the Lender.

 

		3.	CONDITIONS PRECEDENT

 

		3.1	The Lender shall only be obliged to comply with Clause 2.2 (The Facility) if, on or before
the Utilisation Date, it has received:

 

		(a)	a copy of the Acquisition Agreement duly executed by each of the parties thereto;

 

		(b)	evidence that the Borrower (or a wholly-owned subsidiary thereof) has obtained, from such financial
institutions as it may select, binding commitments in an aggregate amount equal to at least $238,000,000, the net proceeds of which
shall be made available directly or indirectly to the Borrower or a subsidiary or thereof and to be applied for the same purpose
as the Loan; and

 

		(c)	evidence that the shareholders of the Borrower have made cash contributions in respect of the consideration
under the Acquisition Agreement in an aggregate amount equal to at least $450,000,000.

 

    3 

     

    

 

		4.	PURPOSE

 

		4.1	The Borrower shall apply the Loan for the payment of:

 

		(a)	the consideration under the Acquisition Agreement; and

 

		(b)	any costs and expenses reasonably incurred by the Borrower or any of its direct or indirect subsidiaries
in connection with the negotiation, preparation, printing and execution of the Acquisition Agreement and this Agreement,

 

and the Borrower undertakes to
the Lender that it will apply the Loan only towards such purposes.

 

		4.2	The Lender shall not be bound to monitor or verify the application of the Loan.

 

		5.	REPAYMENT

 

		5.1	The Borrower shall repay on the Final Maturity Date all remaining amounts then outstanding in relation
to the Facility (for the avoidance of doubt, together with any interest payable in accordance with Clause 8 (Interest)).

 

		5.2	The Borrower may not reborrow any part of the Loan which is repaid or prepaid.

 

		5.3	A certificate of the Lender as to the amount at any time due from the Borrower to it under this
Agreement shall, in the absence of manifest error, be conclusive.

 

		6.	VOLUNTARY PREPAYMENT

 

		6.1	On any date following the date hereof, the Borrower may from time to time, upon not less than 14
days' prior written notice to the Lender, prepay the Loan in cash in dollars on any Business Day, in whole or in part, in an aggregate
minimum amount of $1,000,000 and multiples of $1,000,000 in excess of such minimum amount (or, if less, the remaining amounts then
outstanding in relation to the Facility).

 

		6.2	In respect of any prepayment of the Loan pursuant to this Clause 6, the Borrower shall pay all
accrued and unpaid interest on the principal amount being prepaid to the date of prepayment but without any premium or penalty.

 

		7.	CHANGE OF CONTROL

 

		7.1	Upon the occurrence of:

 

		(a)	a Change of Control; or

 

		(b)	the sale of all or substantially all of the assets of the Borrower and its subsidiaries whether
in a single transaction or a series of related transactions,

 

the Borrower shall promptly notify
the Lender of that event and all outstanding amounts under or in connection with this Agreement will become immediately due and
payable without any premium or penalty.

 

		8.	INTEREST

 

		8.1	Interest on the Loan will accrue at the rate of 8.25% per annum.

 

		8.2	Interest on the Loan shall accrue daily (calculated on the basis of the actual number of days elapsed
and a year of 360 days) and be payable entirely in cash in arrears:

 

		(a)	on each Interest Payment Date with respect to interest accrued on and to each such Interest Payment
Date; and

 

		(b)	on the Final Maturity Date.

 

    4 

     

    

 

		9.	OID FEE

 

		9.1	The Borrower shall pay to the Lender an OID fee (the "OID Fee") in an amount equal
to 1.00% of the Facility Amount.

 

		9.2	The OID Fee shall be payable on the Utilisation Date and only becomes payable if utilisation of
the Facility occurs.

 

		9.3	The Borrower authorises the Lender to deduct an amount equal to the OID Fee from the proceeds of
the Loan.

 

		10.	REPRESENTATIONS

 

The Borrower makes the representations
set out in this Clause 10 to the Lender as at the date of this Agreement.

 

		10.1	The Borrower is a corporation existing under the laws of Delaware.

 

		10.2	The obligations expressed to be assumed by the Borrower in this Agreement are legal, valid, binding
and enforceable obligations (subject to any mandatory provisions of applicable law), save to the extent not materially adverse
to the interests of the Lender.

 

		10.3	All authorisations, consents, approvals, resolutions, licences, exemptions, filings, notarisations
or registrations required to enable the Borrower lawfully to enter into, exercise its rights and comply with its obligations in
this Agreement and to make this Agreement admissible in evidence in its jurisdiction of incorporation have been obtained or effected
and are in full force and effect, save to the extent not materially adverse to the interests of the Lender.

 

		11.	EVENTS OF DEFAULT

 

Each of the events or circumstances set
out in Clauses 11.1 to 11.5 below is an Event of Default.

 

		11.1	The Borrower does not pay on the due date any amount payable pursuant to this Agreement.

 

		11.2	The Borrower:

 

		(a)	declares, makes or pays any dividend, charge, fee or other distribution (or interest on any unpaid
dividend, charge, fee or other distribution) (whether in cash or in kind) on or in respect of its share capital (or any class of
its share capital);

 

		(b)	repays or distributes any dividend or share premium reserve; or

 

		(c)	redeems, repurchases, defeases, retires or repays any of its share capital or resolve to do so,

 

in each case, other than (i) payment
of legal, accounting and other ordinary course corporate overhead or other operational expenses (including payments to any director,
officer, employee, member of management, manager and/or consultant) of any parent thereof and for the payment of franchise or
similar taxes, in each case, to the extent attributable to the ownership of the Borrower and its subsidiaries, (ii) payments
to be applied to repurchase, redeem, retire or otherwise acquire or retire for value the capital stock or other ownership interests
of the Borrower (or any parent company or any subsidiary thereof) held by any future, present or former employee, director, member
of management, officer, manager or consultant (or any affiliate or family member thereof) of the Borrower (or any parent company
or any subsidiary thereof) (or any options, warrants, restricted stock units or stock appreciation rights or other equity-linked
interests issued with respect to any of such capital stock or other ownership interests) and/or (iii) any other such payment
permitted pursuant to the terms of the limited partnership agreement (as amended, novated, supplemented, extended or restated
from time to time) constituting the Co-Investment Entity (as defined in an equity commitment letter entered into on or about the
date of this Agreement).

 

    5 

     

    

 

		11.3	The Closing of the Acquisition Agreement shall have not occurred on or prior to the Outside Date
(as defined in the Acquisition Agreement).

 

		11.4	The Borrower is unable or admits inability to pay its debts as they fall due or is deemed to or
declared to be unable to pay its debts (other than debts owed to any of its subsidiaries or solely by reason of balance sheet liabilities
exceeding balance sheet assets) under applicable law, suspends or threatens to suspend making payments on any of its debts or,
by reason of actual or anticipated financial difficulties, commences negotiations with one or more groups of its creditors (other
than in connection with this Agreement) with a view to rescheduling any of its indebtedness, other than any solvent liquidation
or reorganisation.

 

		11.5	Any corporate action, legal proceedings or other formal procedure or formal step is taken in relation
to:

 

		(a)	the suspension of payments, a moratorium of any indebtedness, winding-up, dissolution, judicial
management, administration or reorganisation (by way of voluntary arrangement, scheme of arrangement, deed of company arrangement
or otherwise) of the Borrower;

 

		(b)	(by reason of actual or anticipated financial difficulties) a composition, compromise, assignment
or arrangement with any class of creditors of the Borrower; or

 

		(c)	the appointment of a liquidator, trustee in bankruptcy, receiver, administrative receiver, judicial
manager, administrator, compulsory manager, voluntary administrator, receiver and manager or other similar officer in respect of
the Borrower or any of its assets, or

 

any analogous procedure or step
is taken in any jurisdiction. This Clause 11.5 shall not apply to (i) any proceeding or step which is discharged, stayed or
dismissed within 20 Business Days of commencement or, if earlier, the date on which it is advertised, or (ii) any step or
procedure which is a solvent liquidation or reorganisation.

 

		11.6	The Borrower shall notify the Lender of any Event of Default promptly upon becoming aware of its
occurrence.

 

		11.7	On and at any time after the occurrence of an Event of Default which is continuing, the Lender
may by notice to the Borrower:

 

		(a)	cancel its commitments with respect to the Facility at which time the Facility shall immediately
be cancelled;

 

		(b)	declare that all or part of the Loan, together with accrued interest, and all other amounts accrued
or outstanding under this Agreement be immediately due and payable, at which time they shall become immediately due and payable;
and/or

 

		(c)	declare that all or part of the Loan be payable on demand, at which time they shall immediately
become payable on demand by the Lender.

 

		12.	COSTS AND EXPENSES

 

The Borrower shall promptly and
in any event within 10 Business Days of demand (provided that no such demand may be made prior to the Utilisation Date unless the
Facility has been cancelled in full) pay the Lender the amount of all costs and expenses (including legal fees subject to any pre-agreed
fee arrangements, and in each case as pre-approved by the Borrower) reasonably incurred by it in connection with the negotiation,
preparation, printing and execution of this Agreement and any other documents referred to in this Agreement.

 

    6 

     

    

 

		13.	PAYMENTS

 

		13.1	All payments made by any party under this Agreement shall be made free from any set-off, counterclaim
or other deduction or withholding of any nature whatsoever, except for deductions or withholdings required to be made by law. So
long as the Lender complies with Clause 22.1, if any deductions or withholdings are required by law to be made from any such payments,
the amount of the payment shall be increased by such amount as will, after the deduction or withholding has been made, leave the
recipient of the payment with the same amount as it would have been entitled to receive in the absence of any such requirement
to make a deduction or withholding.

 

		13.2	All payments to be made by the Borrower to the Lender pursuant to the terms of this Agreement shall
be made in Dollars unless otherwise agreed by the Borrower and the Lender to the following bank account:

 

Bank: Südwestbank AG

 

IBAN:    [                     ]

 

BIC:       [                      ]

 

			or to such other bank account(s) as the Lender shall
notify to the Borrower by not less than 5 Business Days prior notice.

 

		13.3	If any sums would otherwise become due for payment under this Agreement on a day which is not a
Business Day that sum shall become due on the following Business Day of the same calendar month or, if none, on the immediately
preceding Business Day and interest shall be adjusted accordingly.

 

		14.	FURTHER ASSURANCE

 

Each party shall, at its own
cost, promptly execute and deliver all such documents, and do all such things, as the other party may from time to time reasonably
require for the purpose of giving full effect to the provisions of this Agreement and to secure for the other party the full benefit
of the rights, powers and remedies conferred upon it under this Agreement.

 

		15.	ENTIRE AGREEMENT AND REMEDIES

 

		15.1	This Agreement sets out the entire agreement between the parties relating to the subject matter
contained herein and, save to the extent expressly set out in this Agreement, supersedes and extinguishes any prior drafts, agreements,
undertakings, representations, warranties, promises, assurances and arrangements of any nature whatsoever, whether or not in writing,
relating thereto.

 

		15.2	This Agreement is confidential and shall not be disclosed by any party other than (i) to its
directors, officers, employees and advisers on a need to know basis and who are informed of its confidential nature, (ii) by
the Borrower to (a) the parties to the Acquisition Agreement described in Clause 3.1(a) and (b) the financial institutions
described in Clause 3.1(b) or (iii) as otherwise required by applicable law, regulation or court order.

 

    7 

     

    

 

		16.	WAIVER AND VARIATION

  

		16.1	A failure or delay by a party to exercise any right or remedy provided under this Agreement or
by law, whether by conduct or otherwise, shall not constitute a waiver of that or any other right or remedy, nor shall it preclude
or restrict any further exercise of that or any other right or remedy. No single or partial exercise of any right or remedy provided
under this Agreement or by law, whether by conduct or otherwise, shall preclude or restrict the further exercise of that or any
other right or remedy.

 

		16.2	A waiver of any right or remedy under this Agreement shall only be effective if given in writing
and shall not be deemed a waiver of any subsequent breach or default.

 

		16.3	No variation or amendment of this Agreement shall be valid unless it is in writing and duly executed
by or on behalf of all of the parties to this Agreement. Unless expressly agreed, no variation or amendment shall constitute a
general waiver of any provision of this Agreement, nor shall it affect any rights or obligations under or pursuant to this Agreement
which have already accrued up to the date of variation or amendment and the rights and obligations under or pursuant to this Agreement
shall remain in full force and effect except and only to the extent that they are varied or amended.

 

		17.	INVALIDITY

 

Where any provision of this Agreement
is or becomes illegal, invalid or unenforceable in any respect under the laws of any jurisdiction then such provision shall be
deemed to be severed from this Agreement and, if possible, replaced with a lawful provision which, as closely as possible, gives
effect to the intention of the parties under this Agreement and, where permissible, that shall not affect or impair the legality,
validity or enforceability in that, or any other, jurisdiction of any other provision of this Agreement.

 

		18.	ASSIGNMENT

 

Each party to this Agreement
may assign, transfer, charge and/or otherwise deal with all or any of its rights under this Agreement and/or grant, declare, create
and/or dispose of any right or interest in it, in each case, only with the consent of the other party hereto. The Borrower shall
maintain a “Register” for the recordation of the names and addresses of the Lender and its assigns, and the
principal amount of the Loan owing to each of the Lender and its assigns pursuant to the terms hereof from time to time. The entries
in the Register shall be conclusive absent manifest error.

 

		19.	NOTICES

 

		19.1	Any notice or other communication given under this Agreement or in connection with the matters
contemplated herein shall, except where otherwise specifically provided, be in writing in the English language, addressed as provided
in Clause 19.2 and served:

 

		(a)	by leaving it at the relevant address in which case it shall be deemed to have been given upon
delivery to that address;

 

		(b)	by pre-paid airmail, in which case it shall be deemed to have been given five Business Days after
the date of posting; or

 

		(c)	by e-mail, in which case it shall be deemed to have been given when despatched subject to confirmation
of delivery by a delivery receipt,

 

provided that in the case of
sub-clause (c) above any notice despatched other than between the hours of 9:30 a.m. (CET) to 5:30 p.m. (CET) on
a Business Day ("Working Hours") shall be deemed given at the start of the next period of Working Hours.

 

    8 

     

    

 

		19.2	Notices under this Agreement shall be sent for the attention of the person and to the address or
e-mail address, subject to Clause 19.3, as set out below:

  

			For the Lender:

 

		Address:	Bergfeldstrasse 9, 83607 Holzkirchen, Germany

 

		Fax number:	[                ]

 

		For the attention of:	Helmut Jeggle and Sebastian Breyer

 

		E-mail address:	[                ]

 

			For the Borrower:

 

		Address:	c/o EQT Services (UK) Limited,

 

			3rd Floor, 30 Broadwick Street, London, W1F 8JB

 

		For the attention of:	Jason Howard

 

		E-mail address:	[                ]

 

		19.3	Any party to this Agreement may notify the other party of any change to its address or other details
specified in Clause 19.2 provided that such notification shall only be effective on the date specified in such notice or 5 Business
Days after the notice is given, whichever is later.

 

		20.	COUNTERPARTS

 

This Agreement may be executed
in any number of counterparts. Each counterpart shall constitute an original of this Agreement but all the counterparts together
shall constitute but one and the same instrument.

 

		21.	GOVERNING LAW AND JURISDICTION

 

		21.1	This Agreement shall be governed by and construed in accordance with the laws of Germany unless
foreign mandatory law applies.

 

		21.2	Any dispute, controversy or claim arising from or in connection with this Agreement or its validity
shall be finally settled by three arbitrators in accordance with the Arbitration Rules of the German Institution of Arbitration
e.V. (DIS) as applicable at the time of filing the claim, without recourse to the ordinary courts of law. The place of arbitration
shall be Munich. The language of the arbitral proceedings shall be English, provided, however, that written evidence and other
supporting documentation may also be submitted in the German language.

 

		21.3	In the event that mandatory applicable law requires any matter arising out of or in connection
with this Agreement and its execution to be decided upon by an ordinary court of law, the competent courts in Munich shall have
the exclusive jurisdiction.

 

		22.	TAX FORMS

 

		22.1	On the date of this Agreement, upon expiration of such forms, and at any times requested by the
Borrower, the Lender shall promptly deliver to the Borrower an applicable Internal Revenue Service Form W-8, properly completed
and duly executed, establishing (i) a complete exemption from withholding pursuant to Sections 1471 through 1474 of the Code,
and (ii) full eligibility for the benefits of Article XI of the tax treaty applicable between the United States and Germany
with respect to any payment of interest described herein. If any form the Lender previously delivers expires or becomes obsolete
or inaccurate in any respect, the Lender shall update such form. If the Lender is unable to deliver or update any form required
by this Clause 22.1, it shall be deemed to be not in compliance with this Clause 22.1.

 

    9 

     

    

 

This Agreement has been entered into on
the date stated at the beginning of it.

 

 

The Borrower

 

 

For and on behalf of

EQT AVATAR TOPCO, INC.

 

	/s/ Jason Howard	 	/s/ Robert Bradburn
	 		 		
	By:	Jason Howard	 	By:	Robert Bradburn
	 	 	 	 	 
	Title:	President	 	Title:	Vice President and Secretary

 

 

The Lender

 

 

For and on behalf of

SANTO HOLDING (DEUTSCHLAND) GMBH

 

 

	/s/ Helmut Jeggle	 	/s/ Sebastian Breyer
	 	 	 	 	 
	By:	Helmut Jeggle	 	By:	Sebastian Breyer
	 	 	 	 	 
	Title:	 	 	Title:	 

 

[Signature Page to Avatar Loan Agreement]Exhibit 10.10

 

Final Execution Version

 

EMPLOYMENT AGREEMENT

  

This EMPLOYMENT AGREEMENT (this “Agreement”)
is made and entered into as of this 14th day of May, 2019, by and among EQT Avatar Parent L.P., a Delaware limited partnership
(the “Parent”), Certara USA, Inc., a Delaware corporation (the “Company”) and William
Feehery (the “Executive”).

 

W I T N E S S E T H :

 

WHEREAS, the Company desires to employ Executive
and to enter into this Agreement embodying the terms of such employment, and Executive desires to enter into this Agreement and
to accept such employment, subject to the terms and provisions of this Agreement.

 

NOW, THEREFORE, in consideration of the promises
and mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are mutually
acknowledged, the Company and Executive hereby agree as follows:

 

Section 1.       Definitions.
Capitalized terms not otherwise defined elsewhere in this Agreement shall have the meaning set forth in this Section 1.

 

(a)            “Accrued
Obligations” shall mean (i) all accrued but unpaid Base Salary through the date of termination of Executive’s
employment, payable within thirty (30) days following the date of termination, (ii) any unpaid or unreimbursed business expenses
incurred in accordance with Section 6 hereof, payable within thirty (30) days following the date of termination and (iii) any
benefits provided under the Company’s employee benefit plans upon a termination of employment, including rights with respect
to equity participation or accelerated vesting under the Equity Documents, in accordance with the terms contained therein.

 

(b)            “Board”
shall mean the Board of Directors of the Parent.

 

(c)            “Cause”
shall mean (i) Executive’s act(s) of gross negligence or willful misconduct in the course of Executive’s
employment hereunder, (ii) willful failure or refusal by Executive to perform in any material respect his duties or responsibilities,
(iii) misappropriation (or attempted misappropriation) by Executive of any assets or business opportunities of the Company
or any other member of the Company Group, (iv) embezzlement or fraud committed (or attempted) by Executive, or at his direction,
(v) Executive’s conviction of or pleading “guilty” or “ no contest” to, (x) a felony or
(y) any other criminal charge that has, or could be reasonably expected to have, an adverse impact on the performance of Executive’s
duties to the Company or any other member of the Company Group or otherwise result in material injury to the reputation or business
of the Company or any other member of the Company Group, (vi) any material violation by Executive of the policies of the Company,
including but not limited to those relating to sexual harassment or business conduct, to the extent that such violation has, or
could be reasonably expected to have, an adverse impact on the performance of Executive’s duties to the Company or any other
member of the Company Group or otherwise result in material injury to the reputation or business of the Company or any other member
of the Company Group or (vii) Executive’s material breach of this Agreement.

 

    

     

    

 

(d)            “Code”
shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.

 

(e)            “Company
Group” shall mean the Parent together with any of its direct or indirect subsidiaries, including the Company.

 

(f)            “Compensation
Committee” shall mean the committee of the Board designated to make compensation decisions relating to senior executive
officers of the Company Group.

 

(g)            “Confidential
Information” has the meaning set forth in the Restrictive Covenants.

 

(h)            “Disability”
shall mean any physical or mental disability or infirmity of Executive that prevents the performance of Executive’s duties
for a period of (i) ninety (90) consecutive days or (ii) one hundred twenty (120) non-consecutive days during any twelve
(12) month period. Any question as to the existence, extent, or potentiality of Executive’s Disability upon which Executive
and the Company cannot agree shall be determined by a qualified, independent physician selected by the Company and approved by
Executive (which approval shall not be unreasonably withheld, delayed or conditioned). The determination of any such physician
shall be final and conclusive for all purposes of this Agreement.

 

(i)            “Good
Reason” shall mean, without Executive’s consent, (i) a material demotion in Executive’s title, duties,
or responsibilities as set forth in Section 3 hereof, (ii) a change in the geographic location of Executive’s principal
place of employment that is more than fifty (50) miles from Executive’s principal place of employment on the date on which
Executive commences employment with the Company, (iii) a material reduction in Base Salary set forth in Section 4(a) hereof
or Target Annual Bonus opportunity set forth in Section 4(b) hereof, or (iv) any other material breach of a provision
of this Agreement by the Company (other than a provision that is covered by clause (i), (ii) or (iii) above). Executive
acknowledges and agrees that his exclusive remedy in the event of any breach of this Agreement shall be to assert Good Reason pursuant
to the terms and conditions of Section 7(f) hereof. Notwithstanding the foregoing, during the Term of Employment, in
the event that the Board reasonably believes that Executive may have engaged in conduct that could constitute Cause hereunder,
the Board may, in its sole and absolute discretion, suspend Executive from performing his duties hereunder, and in no event shall
any such suspension constitute an event pursuant to which Executive may terminate employment with Good Reason or otherwise constitute
a breach hereunder; provided, that no such suspension shall alter the Company’s obligations under this Agreement during
such period of suspension.

 

(j)            “Person”
shall mean any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company,
trust (charitable or non-charitable), unincorporated organization, or other form of business entity.

 

(k)           “Release
of Claims” shall mean the Release of Claims in substantially the same form attached hereto as Exhibit A (as
the same may be revised from time to time for changes in applicable law, as mutually agreed in writing by the Company and Executive).

 

    -2-

     

    

 

(l)            “Restrictive
Covenants” shall mean the Restrictive Covenants attached as Appendix A to Executive’s Class B Profits Interest
Unit Award Agreement (the “Award Agreement”), a copy of which is attached hereto as Exhibit B.

 

(m)          “Severance
Term” shall mean the twelve (12) month period following Executive’s termination by the Company without Cause (other
than by reason of death or Disability) or by Executive with Good Reason.

 

Section 2.       Acceptance
and Term of Employment.

 

The Company agrees to employ Executive, and
Executive agrees to serve the Company, on the terms and conditions set forth herein. Executive’s employment hereunder shall
commence on June 3, 2019 and continue until terminated as provided in Section 7 hereof (“Term of Employment”).

 

Section 3.       Position,
Duties, and Responsibilities; Place of Performance.

 

(a)            Position,
Duties, and Responsibilities. During the Term of Employment, Executive shall be employed and serve as the Chief Executive Officer
of the Company (together with such other position or positions consistent with Executive’s title as the Board shall specify
from time to time) and shall have such duties and responsibilities commensurate with such title. All business unit Presidents of
the Company and all functional unit heads of the Company shall report to Executive. During the Term of Employment, Executive shall
serve as a member of the Board and also agrees to serve as an officer and/or director of any other member of the Company Group,
in each case without additional compensation.

 

(b)            Performance.
Executive shall devote his full business time, attention, skill, and best efforts to the performance of his duties under this Agreement
and shall not engage in any other business or occupation during the Term of Employment, including, without limitation, any activity
that (y) conflicts with the interests of the Company or any other member of the Company Group or (z) interferes with
the proper and efficient performance of Executive’s duties for the Company. Notwithstanding the foregoing, nothing herein
shall preclude Executive from (i) serving, with the prior written consent of the Board, as a member of the board of directors
or advisory board (or the equivalent in the case of a non-corporate entity) of a non-competing for-profit business and one or more
charitable organizations, provided, however, that this Agreement shall serve as written consent of the Board for Executive to serve
as a member of the board of directors of West Pharmaceutical Services, Inc., (ii) engaging in charitable activities and
community affairs, and (iii) managing Executive’s personal investments and affairs; provided, however,
that the activities set out in clauses (i), (ii), and (iii) shall be limited by Executive so as not to materially interfere,
individually or in the aggregate, with the performance of his duties and responsibilities hereunder.

 

(c)            Principal
Place of Employment. Executive’s principal place of employment shall be in Pennsylvania, although Executive understands
and agrees that he may be required to travel from time to time for business reasons including, without limitation, the Company’s
headquarters in Princeton, New Jersey, and the Company’s other offices.

 

    -3-

     

    

 

Section 4.       Compensation.

 

During the Term of Employment, Executive shall
be entitled to the following compensation:

 

(a)            Base
Salary. Executive shall be paid an annualized Base Salary (the “Base Salary”), payable in accordance with
the regular payroll practices of the Company, of $750,000, with increases, if any, as may be approved in writing by the Compensation
Committee.

 

(b)            Annual
Bonus. Executive shall be eligible for an annual incentive bonus award determined by the Compensation Committee in respect
of each fiscal year during the Term of Employment (the “Annual Bonus”). The target Annual Bonus for each fiscal
year shall be 60% of Base Salary (the “Target Annual Bonus”), with the actual Annual Bonus, which may be higher
than the Target Annual Bonus, payable being based upon the level of achievement of annual Company and individual performance objectives
for such fiscal year, as determined by the Board (or Compensation Committee) in consultation with Executive. The Annual Bonus shall
otherwise be subject to the terms and conditions of the annual bonus plan adopted by the Board or the Compensation Committee, if
any, under which bonuses are generally payable to senior executives of the Company, as in effect from time to time. The Annual
Bonus shall be paid in cash to Executive at the same time as annual bonuses are generally payable to other senior executives of
the Company, but in no event later than April 15th of the year following the year to which such Annual bonus relates,
subject to Executive’s continuous employment through the end of the fiscal year to which such Annual Bonus relates (subject
to Section 7 below). The Annual Bonus for the 2019 shall be no less than the Target Annual Bonus, prorated based on Executive’s
service in 2019; provided, that to the extent that actual performance exceeds the target performance objectives for 2019, Executive
will be eligible to receive an Annual Bonus that exceeds the prorated Target Annual Bonus.

 

(c)            Equity
Participation. In connection with the commencement of Executive’s employment hereunder, Executive shall be entitled to
participate in and, on the date on which Executive’s employment hereunder commences, shall receive a grant under the EQT
Avatar Parent L.P. 2017 Class B Profits Interest Unit Incentive Plan, pursuant to the terms of such plan, the Amended and
Restated Limited Partnership Agreement of the Parent, dated August 15, 2017, and the Award Agreement (the “Equity
Documents”). Executive’s equity participation shall be exclusively governed by the terms of the Equity Documents.

 

Section 5.       Employee
Benefits.

 

During the Term of Employment, Executive shall
be entitled to participate in health, insurance, retirement, and other benefits provided generally to senior executives of the
Company. Executive shall also be entitled twenty-five (25) vacation days and to the same number of holidays and sick days, as well
as any other benefits, in each case as are generally allowed to senior executives of the Company in accordance with the Company
policy as in effect from time to time. Nothing contained herein shall be construed to limit the Company’s ability to amend,
suspend, or terminate any employee benefit plan or policy at any time, and the right to do so is expressly reserved.

 

    -4-

     

    

 

Section 6.       Reimbursement
of Expenses.

 

(a)            Executive
is authorized to incur reasonable business expenses in carrying out his duties and responsibilities under this Agreement, and the
Company shall promptly reimburse him for all such reasonable business expenses, subject to documentation in accordance with the
Company’s policy, as in effect from time to time.

 

(b)            The
Company agrees to promptly reimburse Executive for all reasonable and documented legal fees incurred by Executive in connection
with the review and negotiation of this Agreement and the Equity Documents as well as for all reasonable and documented costs,
including legal fees, incurred by Executive in connection with the enforcement of his rights under this Agreement and the Equity
Documents.

 

Section 7.       Termination
of Employment.

 

(a)            General.
The Term of Employment, and Executive’s employment hereunder, shall terminate upon the earliest to occur of (i) Executive’s
death, (ii) a termination by reason of a Disability, (iii) a termination by the Company with or without Cause, and (iv) a
termination by Executive with or without Good Reason. Except as otherwise expressly required by law (e.g., COBRA) or as specifically
provided herein, all of Executive’s rights to Base Salary, Annual Bonus, employee benefits and other compensatory amounts
hereunder (if any) shall cease upon the termination of Executive’s employment hereunder.

 

(b)            Deemed
Resignation. Upon any termination of Executive’s employment for any reason, except as may otherwise be requested by the
Company in writing and agreed upon in writing by Executive, Executive shall be deemed to have resigned from any and all directorships,
committee memberships, and any other positions Executive holds with the Company or any other member of the Company Group.

 

(c)            Termination
Due to Death or Disability. Executive’s employment shall terminate automatically upon his death. The Company may terminate
Executive’s employment immediately upon the occurrence of a Disability, such termination to be effective upon Executive’s
receipt of written notice of such termination. Upon Executive’s death or in the event that Executive’s employment is
terminated due to his Disability, Executive or his estate or his beneficiaries, as the case may be, shall be entitled to:

 

(i)            The
Accrued Obligations;

 

(ii)           Any
unpaid Annual Bonus in respect of any completed fiscal year that has ended prior to the date of such termination, which amount
shall be paid at such time annual bonuses are paid to other senior executives of the Company, but in no event later than the date
that is 21⁄2 months following the last day of the fiscal year in which such termination occurred (the “Prior Year
Bonus Amount”); and

 

(iii)           Subject
to satisfaction of the applicable performance objectives applicable for the fiscal year in which such termination occurs, an amount
equal to (A) the Annual Bonus otherwise payable to Executive for the fiscal year in which such termination occurred, assuming
Executive had remained employed through the applicable payment date, multiplied by (B) a fraction, the numerator of which
is the number of days elapsed from the commencement of such fiscal year through the date of such termination and the denominator
of which is 365 (or 366, as applicable), which amount shall be paid at such time annual bonuses are paid to other senior executives
of the Company, but in no event later than the date that is 21⁄2 months following the last day of the fiscal year in which
such termination occurred (the “Current Year Bonus Amount”).

 

    -5-

     

    

 

Following Executive’s death or a termination of Executive’s
employment by reason of a Disability, except as set forth in this Section 7(c), Executive shall have no further rights to
any compensation or any other benefits under this Agreement.

 

(d)            Termination
by the Company for Cause.

 

(i)            The
Company may terminate Executive’s employment at any time for Cause, effective upon delivery to Executive of written notice
of such termination; provided, however, that with respect to any Cause termination relying on clause (i), (ii), (vi),
or (vii) of the definition of Cause, to the extent that such act or acts or failure or failures to act are curable, Executive
shall be given not less than thirty (30) days’ written notice by the Board of the Company’s intention to terminate
him for Cause, such notice to state in detail the particular act or acts or failure or failures to act that constitute the grounds
on which the proposed termination for Cause is based, and such termination shall be effective at the expiration of such thirty
(30)-day notice period unless Executive has fully cured such act or acts or failure or failures to act that give rise to Cause
during such period.

 

(ii)            In
the event that the Company terminates Executive’s employment for Cause, he shall be entitled only to the Accrued Obligations.
Following such termination of Executive’s employment for Cause, except as set forth in this Section 7(d)(ii), Executive
shall have no further rights to any compensation or any other benefits under this Agreement.

 

(e)            Termination
by the Company without Cause. The Company may terminate Executive’s employment without Cause by giving Executive thirty
(30) days’ written notice of such termination. In the event that Executive’s employment is terminated by the Company
without Cause (other than due to death or Disability), Executive shall be entitled to:

 

(i)            The
Accrued Obligations;

 

(ii)          The
Prior Year Bonus Amount;

 

(iii)         The
Current Year Bonus Amount;

 

(iv)         An
amount equal to the sum of (x) Base Salary, plus (y) the Target Annual Bonus, such amount to be paid in substantially
equal payments during the Severance Term, and payable in accordance with the Company’s regular payroll practices; and

 

    -6-

     

    

 

(v)            Subject
to Executive’s election of COBRA continuation coverage under the Company’s group health plan, payment, on the first
regularly scheduled payroll date of each month during the Severance Term, of an amount equal to the difference between the monthly
COBRA premium cost and the monthly contribution paid by active employees for the same level of coverage; provided, that
the payments described in this clause (iii) shall cease earlier than the expiration of the Severance Term in the event that
Executive and his eligible dependents become eligible to receive any health benefits as a result of Executive’s subsequent
employment or service during the Severance Term.

 

Notwithstanding the foregoing, the payments and benefits described
in clauses (ii), (iii), (iv) and (v) above shall immediately terminate, and the Company shall have no further obligations
to Executive with respect thereto, in the event that Executive breaches the Restrictive Covenants. Following such termination of
Executive’s employment by the Company without Cause, except as set forth in this Section 7(e), Executive shall have
no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Executive’s
sole and exclusive remedy upon a termination of employment by the Company without Cause shall be receipt of the Severance Benefits.

 

(f)            Termination
by Executive with Good Reason. Executive may terminate his employment with Good Reason by providing the Company thirty (30)
days’ written notice setting forth in reasonable specificity the event that constitutes Good Reason, which written notice,
to be effective, must be provided to the Company within thirty (30) days of the occurrence of such event (or the date Executive
became aware of such event, if later). During such thirty (30)-day notice period, the Company shall have a cure right (if curable),
and if not cured within such period, Executive must terminate his employment within thirty (30) days following the end of such
cure period, and Executive shall be entitled to the same payments and benefits as provided in Section 7(e) hereof for
a termination by the Company without Cause, subject to the same conditions on payment and benefits as described in Section 7(e) hereof.
Following such termination of Executive’s employment by Executive with Good Reason, except as set forth in this Section 7(f),
Executive shall have no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt,
Executive’s sole and exclusive remedy upon a termination of employment with Good Reason shall be receipt of the Severance
Benefits.

 

(g)            Termination
by Executive without Good Reason. Executive may terminate his employment without Good Reason by providing the Company thirty
(30) days’ written notice of such termination. In the event of a termination of employment by Executive under this Section 7(g),
Executive shall be entitled only to the Accrued Obligations. In the event of termination of Executive’s employment under
this Section 7(g), the Company may, in its sole and absolute discretion, by written notice accelerate such date of termination
without changing the characterization of such termination as a termination by Executive without Good Reason. Following such termination
of Executive’s employment by Executive without Good Reason, except as set forth in this Section 7(g), Executive shall
have no further rights to any compensation or any other benefits under this Agreement.

 

    -7-

     

    

 

(h)            Release.
Notwithstanding any provision herein to the contrary, the payment of any amount or provision of any benefit pursuant to subsection
(d) or (e) of this Section 7 (collectively, the “Severance Benefits”), other than the Accrued
Obligations, shall be conditioned upon Executive’s execution, delivery to the Company, and non-revocation of the Release
of Claims (and the expiration of any revocation period contained in such Release of Claims) within sixty (60) days following the
date of Executive’s termination of employment hereunder (the “Release Execution Period”). If Executive
fails to execute the Release of Claims in such a timely manner so as to permit any revocation period to expire prior to the end
of such sixty (60) day period, or timely revokes his acceptance of such release following its execution, Executive shall not be
entitled to any of the Severance Benefits. No portion of the Severance (other than Accrued Obligations) shall be paid until the
Release has become effective and all such amounts shall commence to be paid on the first regular payroll date of the Company after
the Release has become effective; provided, that, if the Release Execution Period overlaps two calendar years, the first
payment shall not be made sooner than the first day of the second year, and shall include any missed payments.

 

Section 8.       Certain
Payments.

 

In the event that (i) Executive is entitled
to receive any payment, benefit or distribution of any type to or for the benefit of Executive, whether paid or payable, provided
or to be provided, or distributed or distributable, pursuant to the terms of this Agreement or otherwise (collectively, the “Payments”),
and (ii) the net after-tax amount of such Payments, after Executive has paid all taxes due thereon (including, without limitation,
taxes due under Section 4999 of the Code) is less than the net after-tax amount of all such Payments otherwise due to Executive
in the aggregate, if such Payments were reduced to an amount equal to 2.99 times Executive’s “base amount” (as
defined in Section 280G(b)(3) of the Code), then the aggregate amount of such Payments payable to Executive shall be
reduced to an amount that will equal 2.99 times Executive’s base amount. To the extent such aggregate parachute payment amounts
are required to be so reduced, the parachute payment amounts due to Executive (but no non-parachute payment amounts) shall be reduced
in the following order: (i) the parachute payments that are payable in cash shall be reduced (if necessary, to zero) with
amounts that are payable last reduced first; (ii) payments and benefits due in respect of any equity, valued at full value
(rather than accelerated value), with the highest values reduced first (as such values are determined under Treasury Regulation
Section 1.280G-1, Q&A 24); and (iii) all other non-cash benefits not otherwise described in clause (ii) of this
Section 8 reduced last. Notwithstanding the foregoing, the Company will use its good faith best efforts to solicit shareholder
approval of Executive’s “excess parachute payments” in accordance with Section 280G of the Code and the
regulations promulgated thereunder if Q&A 7 of the 280G regulations is applicable and Executive first waives the right to receive
excess parachute payments unless approved by shareholders.

 

Section 9.       Restrictive
Covenants

 

Executive acknowledges and recognizes the highly competitive
nature of the business of the Company Group, that access to Confidential Information renders Executive special and unique within
the industry of the Company Group, and that Executive will have the opportunity to develop substantial relationships with existing
and prospective clients, accounts, customers, consultants, contractors, investors, and strategic partners of the Company Group
during the course of and as a result of Executive’s employment with the Company. In light of the foregoing, as a condition
of Executive’s employment by the Company, and in consideration of Executive’s employment hereunder and the compensation
and benefits provided herein, Executive acknowledges and agrees to the Restrictive Covenants, the terms of which are incorporated
herein by reference and made a part hereof. Executive further recognizes and acknowledges that the restrictions and limitations
set forth in the Restrictive Covenants are reasonable and valid in geographical and temporal scope and in all other respects and
are essential to protect the value of the business and assets of the Company Group.

 

    -8-

     

    

 

Section 10.    Representations
and Warranties of Executive.

 

Executive represents and warrants to the Company
that:

 

(a)            Executive
is entering into this Agreement voluntarily and that his employment hereunder and compliance with the terms and conditions hereof
will not conflict with or result in the breach by him of any agreement to which he is a party or by which he may be bound;

 

(b)            Executive
has not violated, and in connection with his employment with the Company will not violate, any non-solicitation, non-competition,
or other similar covenant or agreement with any Person by which he is or may be bound;

 

(c)            In
connection with his employment with the Company, Executive will not use any confidential or proprietary information he may have
obtained in connection with employment or service with any prior service recipient; and

 

(d)            Executive
has not been terminated from any prior employer or service recipient, or otherwise disciplined in connection any such relationship,
in connection with, or as a result of, any claim of workplace sexual harassment or sex or gender discrimination, and to Executive’s
knowledge, Executive has not been the subject of any investigation, formal allegation, civil or criminal complaint, charge, or
settlement regarding workplace sexual harassment or sex or gender discrimination.

 

Section 11.    Taxes.

 

The Company may withhold from any payments
made under this Agreement all applicable taxes, including but not limited to income, employment, and social insurance taxes, as
shall be required by law. Executive acknowledges and represents that the Company has not provided any tax advice to him in connection
with this Agreement and that he has been advised by the Company to seek tax advice from his own tax advisors regarding this Agreement
and payments that may be made to him pursuant to this Agreement, including specifically, the application of the provisions of Section 409A
of the Code to such payments.

 

    -9-

     

    

 

Section 12.    Set
Off; Mitigation.

 

The Company’s obligation to pay Executive
the amounts provided and to make the arrangements provided hereunder shall be subject to set-off, counterclaim, or recoupment of
amounts owed by Executive to the Company or its affiliates; provided, however, that to the extent any amount so subject
to set-off, counterclaim, or recoupment is payable in installments hereunder, such set-off, counterclaim, or recoupment shall not
modify the applicable payment date of any installment, and to the extent an obligation cannot be satisfied by reduction of a single
installment payment, any portion not satisfied shall remain an outstanding obligation of Executive and shall be applied to the
next installment only at such time the installment is otherwise payable pursuant to the specified payment schedule. Executive shall
not be required to mitigate the amount of any payment provided pursuant to this Agreement by seeking other employment or otherwise,
and except as provided in Section 7(e)(v) hereof, the amount of any payment provided for pursuant to this Agreement shall
not be reduced by any compensation earned as a result of Executive’s other employment or otherwise.

 

Section 13.    Key
Man Insurance

 

Within thirty (30) days of the date Executive
commences employment, the Company will procure one or more “key man” insurance policies that will provide Executive
(or his beneficiaries or legal representatives, as the case may be) with a benefit not less than one times his Base Salary plus
Target Annual Bonus in connection with a termination of his employment due to his death or Disability.

 

Section 14.    Additional
Section 409A Provisions.

 

Notwithstanding any provision in this Agreement
to the contrary:

 

(a)           Any
payment otherwise required to be made hereunder to Executive at any date as a result of the termination of Executive’s employment
shall be delayed for such period of time as may be necessary to meet the requirements of Section 409A(a)(2)(B)(i) of
the Code (the “Delay Period”). On the first business day following the expiration of the Delay Period, Executive
shall be paid, in a single cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding
sentence, and any remaining payments not so delayed shall continue to be paid pursuant to the payment schedule set forth herein.

 

(b)           Each
payment in a series of payments hereunder shall be deemed to be a separate payment for purposes of Section 409A of the Code.

 

(c)           Notwithstanding
anything herein to the contrary, the payment (or commencement of a series of payments) hereunder of any nonqualified deferred compensation
(within the meaning of Section 409A of the Code) upon a termination of employment shall be delayed until such time as Executive
has also undergone a “separation from service” as defined in Treas. Reg. 1.409A-1(h), at which time such nonqualified
deferred compensation (calculated as of the date of Executive’s termination of employment hereunder) shall be paid (or commence
to be paid) to Executive on the schedule set forth in this Section 7 as if Executive had undergone such termination of employment
(under the same circumstances) on the date of his ultimate “separation from service.”

 

    -10-

     

    

 

(d)           To
the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified
deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement shall be made
by the Company no later than the last day of the taxable year following the taxable year in which such expense was incurred by
Executive, (ii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another
benefit, and (iii) the amount of expenses eligible for reimbursement or in-kind benefits provided during any taxable year
shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided,
however, that the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement covered
by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement
is in effect.

 

(e)           While
the payments and benefits provided hereunder are intended to be structured in a manner to avoid the implication of any penalty
taxes under Section 409A of the Code, in no event whatsoever shall any member of the Company Group be liable for any additional
tax, interest, or penalties that may be imposed on Executive as a result of Section 409A of the Code or any damages for failing
to comply with Section 409A of the Code (other than for withholding obligations or other obligations applicable to employers,
if any, under Section 409A of the Code).

 

Section 15.    Successors
and Assigns; No Third-Party Beneficiaries.

 

(a)           The
Company. This Agreement shall inure to the benefit of the Company and its respective successors and assigns. Neither this Agreement
nor any of the rights, obligations, or interests arising hereunder may be assigned by the Company to a Person (other than another
member of the Company Group, or its or their respective successors) without Executive’s prior written consent (which shall
not be unreasonably withheld, delayed, or conditioned); provided, however, that in the event of a sale of all or
substantially all of the assets of the Company or any direct or indirect division or subsidiary thereof to which Executive’s
employment primarily relates, the Company may provide that this Agreement will be assigned to, and assumed by, the acquiror of
such assets, division or subsidiary, as applicable, without Executive’s consent.

 

(b)           Executive.
Executive’s rights and obligations under this Agreement shall not be transferable by Executive by assignment or otherwise,
without the prior written consent of the Company; provided, however, that if Executive shall die, all amounts then
payable to Executive hereunder shall be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee,
or other designee, or if there be no such designee, to Executive’s estate.

 

(c)           No
Third-Party Beneficiaries. Except as otherwise set forth in Section 7(c) or Section 15(b) hereof, nothing
expressed or referred to in this Agreement will be construed to give any Person other than the Company, the other members of the
Company Group, and Executive any legal or equitable right, remedy, or claim under or with respect to this Agreement or any provision
of this Agreement.

 

    -11-

     

    

 

Section 16.    Waiver
and Amendments.

 

Any waiver, alteration, amendment, or modification
of any of the terms of this Agreement shall be valid only if made in writing and signed by each of the parties hereto; provided,
however, that any such waiver, alteration, amendment, or modification must be consented to on the Company’s behalf
by the Board. No waiver by either of the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect
to any subsequent occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as a
continuing waiver.

 

Section 17.    Severability.

 

If any covenants or such other provisions
of this Agreement are found to be invalid or unenforceable by a final determination of a court of competent jurisdiction, (a) the
remaining terms and provisions hereof shall be unimpaired, and (b) the invalid or unenforceable term or provision hereof shall
be deemed replaced by a term or provision that is valid and enforceable and that comes closest to expressing the intention of the
invalid or unenforceable term or provision hereof.

 

Section 18.    Governing
Law; Waiver of Jury Trial; Arbitration.

 

THIS AGREEMENT IS GOVERNED BY AND IS TO BE
CONSTRUED UNDER THE LAWS OF THE STATE OF DELAWARE. EACH PARTY TO THIS AGREEMENT ALSO HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN
CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT.

 

Section 19.    Notices.

 

(a)           Place
of Delivery. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or
delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice
mailed or delivered to the other party as herein provided; provided, however, that unless and until some other address
be so designated, all notices and communications by Executive to the Company shall be mailed or delivered to the Company at its
principal executive office, and all notices and communications by the Company to Executive may be given to Executive personally
or may be mailed to Executive at Executive’s last known address, as reflected in the Company’s records.

 

(b)           Date
of Delivery. Any notice so addressed shall be deemed to be given (i) if delivered by hand, on the date of such delivery,
(ii) if mailed by courier or by overnight mail, on the first business day following the date of such mailing, and (iii) if
mailed by registered or certified mail, on the third business day after the date of such mailing.

 

Section 20.    Section Headings.

 

The headings of the sections and subsections
of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof or affect the meaning
or interpretation of this Agreement or of any term or provision hereof.

 

    -12-

     

    

 

Section 21.    Entire
Agreement.

 

This Agreement, together with any exhibits
attached hereto and the Equity Documents, constitutes the entire understanding and agreement of the parties hereto regarding the
employment of Executive. This Agreement supersedes all prior negotiations, discussions, correspondence, communications, understandings,
and agreements between the parties relating to the subject matter of this Agreement.

 

Section 22.    Survival
of Operative Sections.

 

Upon any termination of Executive’s
employment, the provisions of Section 7 through Section 23 of this Agreement (together with any related definitions set
forth on Appendix A) shall survive to the extent necessary to give effect to the provisions thereof.

 

Section 23.    Counterparts.

 

This Agreement may be executed in two or more
counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.
The execution of this Agreement may be by actual or facsimile signature.

 

*     *     *

 

 

[Signatures to appear on the following page.]

 

    -13-

     

    

 

IN WITNESS WHEREOF, the undersigned have executed
this Agreement as of the date first above written.

 

	 	 	CERTARA USA, INC.
	 	 	 
	 	 	 
	 	 	/s/ Richard Traynor
	 	 	By: Richard Traynor
	 	 	Title: Secretary
	 	 	 
	 	 	 
	 	 	EQT AVATAR PARENT L.P.
	 	 	 
	 	 	 
	 	 	/s/ Ethan Waxman
	 	 	By: Ethan Waxman
	 	 	Title:
	 	 	 
	 	 	 
	 	 	EXECUTIVE
	 	 	 
	 	 	 
	 	 	/s/ William Feehery
	 	 	William Feehery

 

    

     

    

 

Exhibit A

 

RELEASE OF CLAIMS

 

As used in this Release of Claims (this “Release”),
the term “claims” will include all claims, covenants, warranties, promises, undertakings, actions, suits, causes of
action, obligations, debts, accounts, attorneys’ fees, judgments, losses, and liabilities, of whatsoever kind or nature,
in law, in equity, or otherwise.

 

For and in consideration of the Severance
Benefits, and other good and valuable consideration, I, William Feehery, for and on behalf of myself and my heirs, administrators,
executors, and assigns, effective the date on which this release becomes effective pursuant to its terms, do fully and forever
release, remise, and discharge each of the Parent and each of its direct and indirect subsidiaries and affiliates, including the
Company, together with their respective officers, directors, partners, shareholders, employees, and agents (collectively, the “Group”)
from any and all claims whatsoever up to the date hereof that I had, may have had, or now have against the Group, for or by reason
of any matter, cause, or thing whatsoever, including any claim arising out of or attributable to my employment or the termination
of my employment with the Company, whether for tort, breach of express or implied employment contract, intentional infliction of
emotional distress, wrongful termination, unjust dismissal, defamation, libel, or slander, or under any federal, state, or local
law dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability, or sexual orientation.
This release of claims includes, but is not limited to, all claims arising under the Age Discrimination in Employment Act (“ADEA”),
Title VII of the Civil Rights Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Family Medical Leave
Act, and the Equal Pay Act, each as may be amended from time to time, and all other federal, state, and local laws, the common
law, and any other purported restriction on an employer’s right to terminate the employment of employees. The release contained
herein is intended to be a general release of any and all claims to the fullest extent permissible by law.

 

I acknowledge and agree that as of the date
I execute this Release, I have no knowledge of any facts or circumstances that give rise or could give rise to any claims
under any of the laws listed in the preceding paragraph.

 

By executing this Release, I specifically
release all claims relating to my employment and its termination under ADEA, a United States federal statute that, among other
things, prohibits discrimination on the basis of age in employment and employee benefit plans.

 

Notwithstanding any provision of this Release
to the contrary, by executing this Release, I am not releasing (i) any claims relating to my rights under Section 7
of the Employment Agreement, including under the Equity Documents, (ii) any claims that cannot be waived by law, or (iii) my
right of indemnification as provided by, and in accordance with the terms of, the Company’s by-laws or a Company insurance
policy or agreement providing such coverage, as any of such may be amended from time to time.

 

I expressly acknowledge and agree that I –

 

▪     Am
able to read the language, and understand the meaning and effect, of this Release;

 

▪       Have
no physical or mental impairment of any kind that has interfered with my ability to read and understand the meaning of this Release
or its terms, and that I am not acting under the influence of any medication, drug, or chemical of any type in entering into this
Release;

 

    

     

    

 

▪       Am
specifically agreeing to the terms of the release contained in this Release because the Company has agreed to pay me the Severance
Benefits in consideration for my agreement to accept it in full settlement of all possible claims I might have or ever had, and
because of my execution of this Release;

 

▪       Acknowledge
that, but for my execution of this Release, I would not be entitled to the Severance Benefits;

 

▪       Understand
that, by entering into this Release, I do not waive rights or claims under ADEA that may arise after the date I execute this
Release;

 

▪       Had
or could have [twenty-one (21)][forty-five (45)]1 days
from the date of my termination of employment (the “Release Expiration Date”) in which to review and consider this
Release, and that if I execute this Release prior to the Release Expiration Date, I have voluntarily and knowingly waived
the remainder of the review period;

 

▪       Have
not relied upon any representation or statement not set forth in this Release or my Employment Agreement made by the Company or
any of its representatives;

 

▪       Was
advised to consult with my attorney regarding the terms and effect of this Release; and

 

▪       Have
signed this Release knowingly and voluntarily.

 

I represent and warrant that I have not previously
filed, and to the maximum extent permitted by law agree that I will not file, a complaint, charge, or lawsuit against any member
of the Group regarding any of the claims released herein. If, notwithstanding this representation and warranty, I have filed
or file such a complaint, charge, or lawsuit, I agree that I shall cause such complaint, charge, or lawsuit to be dismissed
with prejudice and shall pay any and all costs required in obtaining dismissal of such complaint, charge, or lawsuit, including
without limitation the attorneys’ fees of any member of the Group against whom I have filed such a complaint, charge, or
lawsuit. This paragraph shall not apply, however, to a claim of age discrimination under ADEA or to any non-waivable right to file
a charge with the United States Equal Employment Opportunity Commission (the “EEOC”); provided, however,
that if the EEOC were to pursue any claims relating to my employment with Company, I agree that I shall not be entitled to
recover any monetary damages or any other remedies or benefits as a result and that this Release and the Severance Benefits will
control as the exclusive remedy and full settlement of all such claims by me.

 

 

1
        To be selected based on whether applicable termination was “in connection with
an exit incentive or other employment termination program” (as such phrase is defined in the Age Discrimination in Employment
Act of 1967).

 

    -2-

     

    

 

Nothing in this Release shall prohibit or
impede me from communicating, cooperating or filing a complaint with any Governmental Entity with respect to possible violations
of any U.S. federal, state or local law or regulation, or otherwise making disclosures to any Governmental Entity, in each case,
that are protected under the whistleblower provisions of any such law or regulation; provided, that in each case such communications
and disclosures are consistent with applicable law. I understand and acknowledge that an individual shall not be held criminally
or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence
to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected
violation of law, or (2) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under
seal. I understand and acknowledge further that an individual who files a lawsuit for retaliation by an employer for reporting
a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information
in the court proceeding, if the individual files any document containing the trade secret under seal; and does not disclose the
trade secret, except pursuant to court order. Except as otherwise provided in this paragraph or under applicable law, under no
circumstance am I authorized to disclose any information covered by the Company’s attorney-client privilege or attorney work
product, or the Company’s trade secrets, without the prior written consent of the Company’s General Counsel or other
officer designated by the Company. I do not need the prior authorization of (or to give notice to) any member of the Company Group
regarding any communication, disclosure, or activity permitted by this paragraph.

 

I hereby agree to waive any and all claims
to re-employment with the Company or any other member of the Company Group and affirmatively agree not to seek further employment
with the Company or any other member of the Company Group.

 

Notwithstanding anything contained herein
to the contrary, this Release will not become effective or enforceable prior to the expiration of the period of seven (7) calendar
days following the date of its execution by me (the “Revocation Period”), during which time I may revoke my
acceptance of this Release by notifying the Company, in writing, delivered to the Company at its principal executive office, marked
for the attention of its General Counsel, with copy to the Board. To be effective, such revocation must be received by the Company
no later than 11:59 p.m. on the seventh (7th) calendar day following the execution of this Release. Provided
that the Release is executed and I do not revoke it during the Revocation Period, the eighth (8th) day following the
date on which this Release is executed shall be its effective date. I acknowledge and agree that if I revoke this Release during
the Revocation Period, this Release will be null and void and of no effect, and neither the Company nor any other member of the
Group will have any obligations to pay me the Severance Benefits.

 

The provisions of this Release shall be binding
upon my heirs, executors, administrators, legal personal representatives, and assigns. If any provision of this Release shall be
held by any court of competent jurisdiction to be illegal, void, or unenforceable, such provision shall be of no force or effect.
The illegality or unenforceability of such provision, however, shall have no effect upon and shall not impair the enforceability
of any other provision of this Release.

 

    -3-

     

    

 

EXCEPT WHERE PREEMPTED BY FEDERAL LAW,
THIS RELEASE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH FEDERAL LAW AND THE LAWS OF THE STATE OF PENNSYLVANIA,
APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAWS.
I HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION, OR PROCEEDING UNDER OR IN CONNECTION WITH THIS
RELEASE.

 

Capitalized terms used, but not defined herein,
shall have the meanings ascribed to such terms in my Employment Agreement, dated May 14, 2019, with the Company (the “Employment
Agreement”).

 

 

	 	 
	 	[Executive]
	 	Date:

 

    -4-

     

    

 

Exhibit B

 

Class B Profits Interest Unit
Agreement

 

[Attached]

 

    -5-

     

    

 

EQT AVATAR PARENT L.P.

2017 CLASS B PROFITS INTEREST UNIT INCENTIVE PLAN

CLASS B PROFITS INTEREST UNIT AWARD AGREEMENT

 

This Class B Profits
Interest Unit Award Agreement (this “Agreement”), is made as of the date set forth on the Master Signature
Page hereto (hereinafter referred to as the “Date of Grant”), between EQT Avatar Parent L.P., a
Delaware limited partnership (the “Partnership”), an0d the individual named on the Master Signature Page hereto
(the “Participant”):

 

R E C I T A L S:

 

WHEREAS, the Partnership
has adopted the EQT Avatar Parent L.P. 2017 Class B Profits Interest Unit Incentive Plan, as amended from time to time (the
 “Plan”), which Plan is incorporated herein by reference and made a part of this Agreement (capitalized
terms used and not otherwise defined in this Agreement shall have the meanings set forth in the Plan or in the Partnership Agreement,
as applicable);

 

WHEREAS, the Participant
is employed by or otherwise provides services to the Partnership or an Affiliate thereof;

 

WHEREAS, the General
Partner has determined that it would be in the best interests of the Partnership to make the award of Class B Profits Interest
Units provided for herein to the Participant pursuant to the Plan and the terms set forth herein; and

 

WHEREAS, the award set
forth herein is designed to compensate the Participant for his time and commitment in the performance of services to the Partnership
or an Affiliate thereof by providing the Participant with a share of the appreciation and profits of the Partnership with respect
to periods beginning after the date hereof.

 

NOW THEREFORE, in consideration
of the mutual covenants hereinafter set forth, the parties hereto agree as follows:

 

1.            Definitions.
Defined terms are as set forth in Exhibit I hereto.

 

2.            Award
of Class B Profits Interest Units.

 

(a)           Class B
Profits Interest Units. Subject to the terms and conditions of this Agreement and the Plan, the Partnership hereby grants to
the Participant an award of the number of Class B Profits Interest Units set forth on the Participant’s Master Signature
Page, with a Distribution Threshold as set forth on such Master Signature Page, in each case subject to adjustment as set forth
in the Plan and this Agreement. The Class B Profits Interest Units shall vest in accordance with Section 3 of this Agreement.

 

(b)           Distributions.
Distributions in respect of Class B Profits Interest Units shall be made to the Participant in accordance with the provisions
of the Partnership Agreement.

 

    

     

    

 

 

3.            Vesting.
The Class B Profits Interest Units granted to the Participant shall vest in accordance with this Section 3. All such
Class B Profits Interest Units shall be unvested on the Date of Grant and shall vest as follows:

 

(a)           Time
Vesting Units: With respect to 50% of the Class B Profits Interest Units subject to this Agreement (the “Time
Vesting Units”), so long as the Participant has not undergone a Termination prior to the applicable vesting date,
25% of the Time Vesting Units will vest on the first anniversary of the Date of Grant (the “First Vesting Date”)
and 2.0833% will vest on each monthly anniversary of the First Vesting Date (such that in the ordinary course, assuming no Termination,
the Time Vesting Units shall fully vest on the fourth anniversary of the Date of Grant); provided, however, that
all unvested Time Vesting Units will vest upon the consummation of a Change in Control.

 

(b)           Performance
Vesting Units: With respect to the remaining 50% of the Class B Profits Interest Units subject to this Agreement (the
 “Performance Vesting Units”), the Performance Vesting Units will vest upon a Measurement Date as follows,
so long as the Participant has not undergone a Termination prior to the applicable vesting date (except as otherwise provided in
Section 4 below):

 

		o	1/3 of the Performance Vesting Units will vest upon the Measurement Date on which the Initial EQT
Investors (as defined in the Partnership Agreement) have achieved a Return on Investment of at least 2.0;

 

		o	1/3 of the Performance Vesting Units will vest upon the Measurement Date on which the Initial EQT
Investors have achieved a Return on Investment of at least 2.5; and

 

		o	1/3 of the Performance Vesting Units will vest upon the Measurement Date on which the Initial EQT
Investors have achieved a Return on Investment of at least 3.0.

 

For purposes of the
above, to the extent the achieved Return on Investment falls between any of the levels described above, in addition to the number
of Performance Vesting Units that vest at the level that is achieved, an additional number of Performance Vesting Units will vest
based on a linear interpolation between the applicable levels between which the Return on Investment falls. Performance Vesting
Units that do not vest prior to or upon the Final Measurement Date will be forfeited upon such Final Measurement Date.

 

    

     

    

 

 

4.           General
Termination of Employment Provisions; Breach of Restrictive Covenants Agreement.

 

(a)           All
vesting of Class B Profits Interest Units will cease immediately upon a Participant’s Termination for any reason, all
unvested Class B Profits Interest Units will be immediately cancelled and forfeited without consideration upon such Termination,
and if such Termination is by the Service Recipient for Cause, all vested Class B Profits Interest Units will be immediately
cancelled and forfeited without consideration upon such Termination. Notwithstanding the foregoing, in the event of the Participant’s
Termination by the Service Recipient without Cause, by the Participant for Good Reason, or due to the Participant’s death
or Disability, (i) the Time-Vesting Units scheduled to vest during the 12 month period following Participant’s date
of Termination shall vest on the date of the Participant’s Termination and (ii) the Participant’s Performance
Vesting Units shall remain outstanding and eligible to vest upon any Measurement Date that occurs during the six-month period following
the date of such Termination, and any Performance Vesting Units that do not vest prior to the expiration of such six-month period
will be immediately cancelled and forfeited without consideration at the end of such period.

 

(b)           Breach
of Restrictive Covenants Agreement. Notwithstanding any other provision of this Agreement, in the event of an RC Breach, all
Class B Profits Interest Units (whether vested or unvested) will immediately be cancelled and forfeited without consideration.

 

5.           Rights
as Holder of Class B Profits Interest Units. The Participant shall be the record owner of the Class B Profits Interest
Units granted hereunder unless and until such Class B Profits Interest Units are forfeited pursuant to Section 4, repurchased
pursuant to Section 10 hereof or transferred in accordance with Section 7, and as record owner shall be entitled to all
rights of a holder of Class B Profits Interest Units; provided, that the Class B Profits Interest Units shall
be subject to the limitations on transfer and encumbrance set forth in this Agreement, the Plan and the Partnership Agreement.

 

6.           Investment
Intent; Other Representations of Participant.

 

(a)            Investment
Intent. The Participant hereby represents and warrants that the Class B Profits Interest Units will be held for investment
purposes and are not being received with a view to distribution thereof, and covenants and agrees to make such other reasonable
and customary representations as requested by the Partnership regarding matters relevant to compliance with applicable securities
laws as are deemed necessary by counsel to the Partnership; and

 

(b)            No
Reliance on the Partnership. In making his or her investment decision with respect to the receipt of the Class B Profits
Interest Units, the Participant has not relied upon the Partnership or any of its Affiliates, or any representative thereof for
any advice of any sort, including, but not limited to, tax or securities law advice.

 

    

     

    

 

7.           Transferability.
The Participant may Transfer, directly or indirectly, any Class B Profits Interest Unit or any interest in any Class B
Profits Interest Unit only with the prior written consent of the Board, which consent shall be withheld or granted in the sole
discretion of the Board, or as otherwise expressly permitted or required under the Partnership Agreement. Any purported assignment,
transfer or grant by the Participant, directly or indirectly, of any Class B Profits Interest Unit or any interest in any
Class B Profits Interest Unit which is made without such prior written consent or pursuant to the terms of the Partnership
Agreement shall be entirely null and void, ab initio.

 

8.           Section 83(b) Election
and Certain Related Income Tax Considerations. As a condition subsequent to the issuance of the Class B Profits Interest
Units pursuant to this Agreement, the Participant shall execute and deliver to each of the Partnership, the entity to whom the
Participant provides services and the Internal Revenue Service (the “IRS”) a timely, valid election under
Section 83(b) of the Code (the “83(b) Election”). The Participant hereby acknowledges
that (x) the Partnership has not provided, and is not hereby providing, the Participant with tax advice regarding the 83(b) Election
and has urged the Participant to consult the Participant’s own tax advisor with respect to the income taxation consequences
thereof, and (y) the Partnership has not advised the Participant to rely on any determination by it or its representatives
as to the fair market value specified in the 83(b) Election and will have no liability to the Participant if the actual fair
market value of the Class B Profits Interest Units on the date hereof exceeds the amount specified in the 83(b) Election.

 

9.           Becoming
a Partner of The Partnership; No Access to Information Regarding The Partnership. As a further condition to the issuance of
the Class B Profits Interest Units pursuant to this Agreement, the Participant shall execute and deliver to the Partnership
a copy of the Partnership Agreement, together with such other documents as the General Partner or the Board may require, evidencing
such Participant’s status as a Partner (as defined in the Partnership Agreement) of the Partnership. Notwithstanding the
Participant’s status as a Partner of the Partnership, the Participant shall have no right, solely by virtue of holding a
Class B Profits Interest Unit, to (a) examine the books and records of or any other information of the Partnership or
(b) obtain any information about the identities of the other Partners of the Partnership (or of the size or nature of such
other Partners’ interests in the Partnership).

 

10.         Right
to Repurchase Class B Profits Interest Units.

 

(a)            The
Class B Profits Interest Units are subject to the Partnership’s right of repurchase (the “Call Right”)
exercisable by the Partnership in its sole discretion during the ninety (90) day period following (x) the later of (i) the
Termination of such Participant’s employment with the Service Recipient for any reason and (ii) the six (6) month
anniversary of the date such Class B Profits Interest Units became vested, and, if later, (y) a breach of any of the
provisions in any Restrictive Covenant Agreement. The Call Right shall expire on the earlier of (i) an IPO or (ii) a
Change in Control.

 

    

     

    

 

(b)            In
the event the Call Right is exercised, the purchase price for the Class B Profits Interest Units subject to the exercised
Call Right shall be the Fair Market Value per unit on the date such Call Right is exercised, provided, however, that in the event
the Participant disagrees with the Fair Market Value as determined by the Board in connection with any repurchase of Class B
Profits Interest Units, the Participant may, within thirty (30) days following the Participant’s receipt of the notice of
the Partnership’s exercise of the Call Right, require the Board to seek an independent appraisal to determine the Fair Market
Value of the Class B Profits Interest Units (an “Outside Appraisal”). Any such Outside Appraisal
shall be made by a qualified accounting firm or investment banking firm or similar firm having substantial experience in the valuation
of similar enterprises in the United States that is mutually agreed upon by the Partnership and the Participant (an “Appraiser”).
The Partnership shall bear 100% of the fees and expenses of the Appraiser; provided, however, that the Participant shall immediately
reimburse the Partnership for 50% of the fees and expenses of the Appraiser if the Fair Market Value of a Class B Profits
Interest Unit as determined by the Appraiser is less than or equal to 110% of the Fair Market Value as determined by the Board.
The determination of Fair Market Value by the Appraiser shall be binding on the parties.

 

(c)            In
the event the Call Right is exercised, the aggregate purchase price for such Class B Profits Interest Units subject to the
exercised Call Right will be payable by the Partnership (or, if applicable, the Initial EQT Investors or one of their affiliates)
in cash in a lump sum within thirty (30) days of the exercise of such repurchase right (or the date on which the Appraiser determines
Fair Market Value, if later) (the “Repurchase Date”),; provided, that if the Partnership is prohibited
from paying in cash under any applicable financing arrangement, any applicable installment may be paid by promissory note in installments
of up to three years. Any amounts not paid in full within thirty (30) days of the Repurchase Date will bear interest at the prime
lending rate in effect as of the Repurchase Date. Notwithstanding any other provision in this Agreement, the Partnership may elect
to pay the purchase price hereunder in shares or other equity securities of one of its respective direct or indirect subsidiaries
with a fair market value equal to the applicable purchase price; provided, that such subsidiary promptly repurchases such shares
or other equity securities for cash equal to the applicable purchase price.

 

11.         Restrictive
Covenants. Participant acknowledges and recognizes the highly competitive nature of the businesses of the Partnership Group
and its Affiliates and accordingly agrees, in Participant’s capacity as an investor and equity holder in the Partnership,
to the provisions of Appendix A to this Agreement. Participant acknowledges and agrees that remedies of the Partnership
Group at law for a breach or threatened breach of any of the provisions of Appendix A would be inadequate and the Partnership
Group would suffer irreparable damages as a result of such breach or threatened breach by Participant, regardless of whether the
Participant then holds Class B Profits Interest Units. In recognition of this fact, the Participant agrees that, in the event
of such a breach or threatened breach, in addition to any remedies at law, the Partnership Group, without posting any bond, shall
be entitled to obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent
injunction or any other equitable remedy which may then be available.

 

    

     

    

 

12.         Partnership
Agreement. Neither the adoption of the Plan nor the grant of any Class B Profits Interest Units pursuant to this Agreement
shall restrict in any way the adoption of any amendment to the Partnership Agreement in accordance with the terms of such agreement.

 

13.         Notices.
Any notice necessary under this Agreement shall be addressed to the Partnership at the principal executive office of the Partnership
and to the Participant at the address appearing in the personnel records of the Partnership (or other member of the Partnership
Group) for the Participant or to either party at such other address as either party hereto may hereafter designate in writing to
the other. Any such notice shall be deemed effective upon receipt thereof by the addressee.

 

14.         Choice
of Law; Forum. ALL ISSUES AND QUESTIONS CONCERNING THE APPLICATION, CONSTRUCTION, VALIDITY, INTERPRETATION AND ENFORCEMENT
OF THIS AGREEMENT AND THE EXHIBITS AND APPENDICES TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE
LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICT OF LAW RULES OR PROVISIONS (WHETHER OF THE
STATE OF DELAWARE OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE
OF DELAWARE (EXCEPT THAT THE PROVISIONS OF SECTION 1 OF APPENDIX A SHALL BE GOVERNED BY THE LAW OF THE STATE WHERE
PARTICIPANT IS PRINCIPALLY EMPLOYED BY THE SERVICE RECIPIENT). EACH OF THE PARTIES HERETO HEREBY (I) IRREVOCABLY SUBMITS TO
THE EXCLUSIVE JURISDICTION OF ANY COURT LOCATED IN THE STATE OF DELAWARE FOR THE PURPOSES OF ANY SUIT, ACTION OR OTHER PROCEEDING
ARISING OUT OF THIS AGREEMENT; (II) AGREES THAT THE SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY U.S. REGISTERED
MAIL TO SUCH PERSON’S ADDRESS SET FORTH HEREIN SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING IN
THE STATE OF DELAWARE WITH RESPECT TO ANY MATTERS TO WHICH IT HAS SUBMITTED TO JURISDICTION AS SET FORTH HEREIN IN THE IMMEDIATELY
PRECEDING CLAUSE (I); AND (III) IRREVOCABLY AND UNCONDITIONALLY WAIVES (AND AGREES NOT TO PLEAD OR CLAIM) ANY OBJECTION TO
THE LAYING OF VENUE OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT IN ANY STATE OR FEDERAL COURT LOCATED IN THE
STATE OF DELAWARE, OR THAT ANY SUCH ACTION, SUIT OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

15.         WAIVER
OF JURY TRIAL. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES, AND SHALL CAUSE ITS AFFILIATES TO WAIVE, ALL
RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER AGREEMENTS
AND INSTRUMENTS DELIVERED HEREUNDER OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

 

    

     

    

 

16.         Class B
Profits Interest Units Subject to Plan and Partnership Agreement. By entering into this Agreement the Participant agrees and
acknowledges that (i) the Participant has received and read a copy of the Plan and the Partnership Agreement and (ii) the
Class B Profits Interest Units are subject to the Plan and the Partnership Agreement, the terms and provisions of such Plan
and Partnership Agreement are hereby incorporated herein by reference. In the event of a conflict between any term or provision
contained herein or therein, the Partnership Agreement shall govern and prevail, and then in decreasing order of seniority, the
Plan and lastly, this Agreement.

 

17.         Rules of
Construction. The parties hereto agree that they have been represented by counsel during the negotiation and execution of this
Agreement and have participated jointly in the drafting of this Agreement and, therefore, waive the application of any Law, holding
or rule of construction providing that ambiguities in an agreement or other document will be construed against the party drafting
such agreement or document.

 

18.         Definitional
Provisions. Defined terms used in this Agreement in the singular shall import the plural and vice versa. Whenever the context
may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. All references herein to Sections
shall be deemed to be references to Sections of this Agreement unless the context shall otherwise require. The words “include,”
 “includes” and “including” shall be deemed to be followed by the phrase “without limitation.”
The words “hereof,” “herein” and “hereunder” and words of similar import when used in this
Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. Any statute or laws defined
or referred to herein shall include any rules, , regulations or forms promulgated thereunder from time to time and as from time
to time amended, modified or supplemented, including by succession of successor rules, regulations or forms. Unless otherwise expressly
provided herein, any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred
to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the
case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes
and references to all attachments thereto and instruments incorporated therein. Any reference to the number of Class B Profits
Interest Units means such Class B Profits Interest Units as appropriately adjusted to give effect to any share combinations,
restructuring or other capitalizations of the Partnership or its capital structure. Any reference herein to the holder of a particular
class or series of Class B Profits Interest Units shall be a reference to such Person solely in its capacity as a holder of
that particular class or series of such Class B Profits Interest Units.

 

19.         Signature
in Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as
if the signatures thereto and hereto were upon the same instrument.

 

[Remainder of Page Intentionally
Blank]

 

    

     

    

 

	 	
         

        *        *        *        *        *

         

        This Agreement between the Partnership
        and the

        Participant named on the Master Signature Page

        hereto is dated and executed as of the date set

        forth on such Master Signature Page.

         

        *        *        *        *        *

         
	 

 

    

     

    

 

Exhibit I

 

Definitions

 

“83(b) Election”
shall have the meaning set forth in Section 8.

 

“Agreement” shall
have the meaning set forth in the Preamble.

 

“Business” shall
have the meaning set forth in Section 1(a) of Appendix A.

 

“Call Right” shall
have the meaning set forth in Section 10(a).

 

“Cause” shall
have the meaning set forth in the Employment Agreement between the Partnership and the Participant dated May 14, 2019.

 

“Change in Control”
means (i) the sale (whether by merger, recapitalization or other sale or business combination transaction) of all or substantially
all of the assets of the Partnership (in one transaction or a series of related transactions) to any person (or group of persons
acting in concert), other than to (A) the Initial EQT Investors or one of their respective affiliates, (B) any employee
benefit plan (or trust forming a part thereof) maintained by the Partnership or any of its subsidiaries, or (C) any other
person of which a majority of its voting power or other equity securities is owned, directly or indirectly, by the Partnership
(any entity in clause (B) or (C), a “Controlled Party”); or (ii) a merger, recapitalization
of the Partnership, or other sale or business combination by the Partnership (in one transaction or a series of related transactions)
to a person (or group of persons acting in concert), in each case, that results in any person (or group of persons acting in concert)
(other than (A) the Initial EQT Investors or their affiliates or (B) any Controlled Party) owning more than 50% of the
equity interests or voting power of the Partnership (or any resulting entity after a merger or business combination transaction).
For the avoidance of doubt, none of an IPO, stock dividend or distribution, stock split, or any other similar capital structure
change shall alone constitute a Change in Control.

 

“Competitive Activities”
shall have the meaning set forth in Section 1(a) of Appendix A.

 

“Confidential Information”
shall have the meaning set forth in Section 2(a)(ii) of Appendix A.

 

“Date of Grant”
shall have the meaning set forth in the Preamble.

 

“Disability” shall
have the meaning set forth in the Employment Agreement between the Partnership and the Participant dated May 14, 2019.

 

“Employment Term”
shall have the meaning set forth in Section 1(a) of Appendix A.

 

    

     

    

 

“Exchange Act” means
the Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations promulgated pursuant thereto.

 

“Fair Market Value”
means the fair market value of a Class B Unit as determined by the Board in good faith assuming a hypothetical orderly
liquidation of the Partnership and without regard to any discount for lack of liquidity or minority interest.

 

“Final Measurement Date”
means the earlier to occur of (i) a Change in Control or (ii) following an IPO, the date upon which the Initial EQT Investors
no longer holds equity securities of the Partnership (or such other entity that an IPO of the Partnership is effectuated through)
representing more than 10% of the outstanding equity securities of such entity.

 

“Good Reason” shall
have the meaning set forth in the Employment Agreement between the Partnership and the Participant dated May 14, 2019.

 

“Governmental Entity”
shall have the meaning set forth in Section 2(a)(v) of Appendix A.

 

“Inventions” shall
have the meaning set forth in Section 2(b)(i) of Appendix A.

 

“IPO” means (i) the
first registered initial public offering in the United States or foreign jurisdiction of the equity securities of the IPO Corporation
or any entity into which the equity securities of the IPO Corporation may be converted in connection with such offering, pursuant
to an effective registration statement under the Securities Act (other than a registration statement on Forms S-4 or S-8 or any
similar form) or pursuant to other applicable foreign Laws or (ii) the date of effectiveness of a registration of a class
of securities of the IPO Corporation or any entity into which the securities of the IPO Corporation may be converted in connection
with such registration under the Exchange Act to be traded on a national securities exchange that has registered with the United
States Securities and Exchange Commission under Section 6 of the Exchange Act.

 

“IPO Corporation”
means the entity that undertakes the IPO as determined by the General Partner of the Partnership.

 

“IRS” shall have
the meaning set forth in Section 8.

 

“Marketable
Securities” means securities that (i) are traded on the New York Stock Exchange, the NASDAQ Stock Market
or any similar national securities exchange, or any successor thereto, and (ii) are, at the time of receipt, registered
pursuant to an effective registration statement filed under the Securities Act and will remain registered until such time as
such securities can be sold by the holder thereof pursuant to Rule 144; provided that Marketable Securities shall not
include any securities of the Partnership (or any entity which the Partnership effectuates an IPO through). The fair market
value of any Marketable Securities will equal the volume-weighted average of the closing prices on the principal securities
exchange on which such Marketable Securities are listed for the (20) trading days preceding the trading day immediately
preceding the day on which a definitive agreement is entered into with respect to the transaction that results in the receipt
of such Marketable Securities by the Initial EQT Investors.

 

    

     

    

 

“Measurement Date”
means (i) prior to the Final Measurement Date, each date upon which the Initial EQT Investors receive Sponsor Cash Amounts,
(ii) in the sole discretion of the Participant, the date of an IPO prior to the Final Measurement Date, or (iii) the
Final Measurement Date.

 

“Participant”
shall have the meaning set forth in the Preamble.

 

“Partnership” shall
have the meaning set forth in the Preamble.

 

“Performance Vesting Units”
shall have the meaning set forth in Section 3(b).

 

“Plan” shall
have the meaning set forth in the Recitals.

 

“Proprietary Rights”
shall have the meaning set forth in Section 2(b)(i) of Appendix A.

 

“RC Breach” means
Participant’s breach of Sections 1(a) and (b) of Appendix A hereto or any similar corresponding provision
applicable to Participant under a written agreement between members of the Partnership Group, from time to time.

 

“Repurchase Date”
shall have the meaning set forth in Section 10(c).

 

“Restrictive Covenant Agreement”
means the restrictive covenants attached hereto as Appendix A or any covenants of non-competition, non-solicitation, non-interference,
no-hire, non-disparagement, confidentiality or similar covenants contained in any employment agreement or similar agreement between
the Participant and a member of the Partnership Group.

 

“Restrictive Covenant Period”
shall have the meaning set forth in Section 1(a) of Appendix A.

 

“Return on Investment”
means, as of any Measurement Date, the quotient obtained by dividing (i) Sponsor Cash Amounts by (ii) Sponsor Cash
Invested; provided, that, (x) in the case of prong (ii) of the definition of Measurement Date, the Return on Investment
achieved by the Initial EQT Investors in connection with an IPO shall be determined based on the offering price to the public
assuming all equity securities of the IPO vehicle held by the Sponsor were disposed of as of such IPO, (y) in the case of
prong (i) of the definition of Final Measurement Date, the Return on Investment achieved by the Initial EQT Investors in
connection with such Final Measurement Date shall be determined as if 100% of the Partnership was sold in connection with such
Change in Control at the price per unit received by the Initial EQT Investors in such Change in Control and (z) in the case
of prong (iii) of the definition of Final Measurement Date, the Return on Investment achieved by the Initial EQT Investors
in connection with such Final Measurement Date shall be determined as if the remaining equity holdings were sold at a fair market
value equal to the volume-weighted average of the closing prices on the principal securities exchange on which such equity holdings
are listed for the twenty (20) trading days preceding the trading day immediately preceding the Final Measurement Date.

 

    

     

    

 

“Securities Act”
means the Securities Act of 1933, as amended from time to time.

 

“Sponsor Cash Amounts”
means, as of any Measurement Date, without duplication, the cumulative amount of all cash (including cash dividends, cash distributions,
and cash proceeds) and the fair market value of any Marketable Securities, in each case actually received by the Initial EQT Investors
on or before such Measurement Date with respect to or in exchange for equity securities of the Partnership (including, in each
case, any portion subject to escrow or holdback and the value of any earnout); provided, however, that Sponsor Cash Amounts,
as determined in, connection with a Change in Control, shall also include the fair market value, as determined by the Board in
good faith, of any securities that are not Marketable Securities received in connection with such Change in Control.

 

“Sponsor Cash Invested”
means, as of any Measurement Date, without duplication, all cash invested by the Initial EQT Investors in equity securities
of the Partnership on or before such Measurement Date, including any additional capital invested in the Partnership by the Initial
EQT Investors following the Closing and through such applicable Measurement Date.

 

“Time Vesting Units”
shall have the meaning set forth in Section 3(a).

 

    

     

    

 

Appendix A

 

Restrictive Covenants

 

1.            Non-Competition;
Non-Solicitation; Non-Interference. Participant acknowledges and recognizes the highly competitive nature of the businesses
of the Partnership Group and its Affiliates and accordingly agrees as follows:

 

(a)           Prior
to the Participant’s Termination for any reason (the “Employment Term”) and until the first anniversary
of Participant’s Termination, Participant will not (i) directly or indirectly, in any geographic location in which the
Partnership Group engages, own, operate, manage, control, invest in, lend to, acquire an interest in, or otherwise engage or participate
in (whether as an employee, independent contractor, consultant, partner, shareholder, joint venturer, investor, or any other type
of participant) the management or conduct of any business activities, whether through selling, distributing, manufacturing, marketing,
purchasing, or otherwise, that compete directly or indirectly with the Partnership or any member of the Partnership Group (“Competitive
Activities”), it being understood that Competitive Activities as of the date hereof include, without limitation,
principally engaging in the business of model based drug development consulting services or technology solutions, including with
respect to discovery, pre-clinical, clinical and postmarketing drug development and regulatory submissions and review and any other
business in which the Partnership is actively engaged at the time of termination (the “Business”).

 

(b)           During
the Employment Term and until the first anniversary of Participant’s Termination, Participant will not directly or indirectly:

 

(i)            (A) solicit
or induce any customer, supplier, licensee, or other business relation (or any actively sought prospective customer, supplier,
licensee, or other business relation) of the Partnership or any member of the Partnership Group to cease doing business with or
materially reduce the amount of business conducted with the Partnership or any member of the Partnership Group, or materially interfere
with the relationship between any such customer, supplier, licensee, or other business relation (or any actively sought prospective
customer, supplier, licensee, or other business relation) and the Partnership or any member of the Partnership Group; or (B) knowingly
or intentionally assist any Person in any substantive or direct way to do, or attempt to do, anything prohibited by clause (A) above;
or

 

(ii)           (A) solicit
or hire, directly or indirectly, for employment, or assist others in hiring, employing, inducing, or soliciting for employment
(except in the performance of Participant’s duties), any employees of the Partnership or any member of the Partnership Group
(or individuals who were employed during the one-year period prior to the termination of Participant’s employment with the
Service Recipient); or (B) knowingly or intentionally assist any Person in any substantive or direct way to do, or attempt
to do, anything prohibited by clause (A) above.

 

    

     

    

 

(c)           If
a final and non-appealable judicial determination is made that any of the provisions of this Section 1 constitutes an unreasonable
or otherwise unenforceable restriction against Participant, the provisions of this Section 1 will not be rendered void but
will be deemed to be modified to the minimum extent necessary to remain in force and effect for the longest period and largest
geographic area that would not constitute such an unreasonable or unenforceable restriction.

 

(d)           The
period of time during which the provisions of this Section 1 shall be in effect shall be extended by the length of time during
which Participant is in breach of the terms hereof.

 

(e)           The
provisions of Section 1 hereof shall survive the termination of Participant’s employment for any reason.

 

2.            Confidentiality;
Intellectual Property.

 

(a)           Confidentiality.

 

(i)            Participant
acknowledges that the Confidential Information obtained by Participant while employed by the Service Recipient is the property
of the Partnership Group. Therefore, Participant agrees that Participant shall not disclose to any unauthorized Person or use for
Participant’s own purposes any Confidential Information without the prior written consent of the Partnership, unless and
to the extent that the aforementioned matters become generally known to and available for use by the public other than as a result
of Participant’s acts or omissions in violation of this Agreement; provided, however, that if Participant receives a request
to disclose Confidential Information pursuant to a deposition, interrogation, request for information or documents in legal proceedings,
subpoena, civil investigative demand, governmental or regulatory process, or similar process, (i) Participant shall, as promptly
as practicable, notify in writing the Partnership, and consult with and reasonably assist the Partnership, at the Partnership’s
expense, in seeking a protective order or request for other appropriate remedy, (ii) in the event that such protective order
or remedy is not obtained, or if the Partnership waives compliance with the terms hereof, Participant shall disclose only that
portion of the Confidential Information which, based on the advice of Participant’s legal counsel, is legally required to
be disclosed and shall exercise reasonable best efforts to provide that the receiving Person shall agree to treat such Confidential
Information as confidential to the extent possible (and permitted under applicable law) in respect of the applicable proceeding
or process, and (iii) the Partnership shall be given an opportunity to review the Confidential Information prior to disclosure
thereof.

 

    

     

    

 

(ii)           For
purposes of this Agreement, “Confidential Information” means information, observations, and data concerning
the business or affairs of the Partnership Group, including, without limitation, all business information (whether or not in written
form) that relates to any member of the Partnership Group, or its customers, suppliers, or contractors or any other third parties
in respect of which the Partnership or any member of the Partnership Group has a business relationship or owes a duty of confidentiality,
or their respective businesses or products, and that is not known to the public generally other than as a result of Participant’s
breach of this Agreement, including but not limited to technical information or reports, formulas, trade secrets, unwritten knowledge
and “know-how,” operating instructions, training manuals, customer lists, customer buying records and habits, product
sales records and documents, and product development, marketing, and sales strategies, market surveys, marketing plans, profitability
analyses, product cost, long-range plans, information relating to pricing, competitive strategies, and new product development,
information relating to any forms of compensation or other personnel-related information, contracts, and supplier lists. Confidential
Information will not include such information known to Participant prior to Participant’s involvement with the Partnership
or any predecessor thereof or information rightfully obtained from a third party (other than pursuant to a breach by Participant
of this Agreement). Without limiting the foregoing, Participant and the Partnership each agree to keep confidential the existence
of, and any information concerning, any dispute between Participant and the Partnership or any member of the Partnership Group,
except that Participant and the Partnership each may disclose information concerning such dispute to the court that is considering
such dispute or to their respective legal counsel, immediate family and advisors (provided that such counsel agrees not to disclose
any such information other than as necessary to the prosecution or defense of such dispute).

 

(iii)          Participant
acknowledges that all notes, memoranda, specifications, devices, formulas, records, files, lists, drawings, documents, models,
equipment, property, computer, software, or intellectual property relating to the businesses of the Partnership Group, in whatever
form (including electronic), and all copies thereof, that are received or created by Participant while an employee of the Service
Recipient (including but not limited to Confidential Information and Inventions) are and shall remain the property of the Partnership
Group, and Participant shall as promptly as practicable return such property to the Partnership upon the termination of Participant’s
employment and, in any event, at the Partnership’s request.

 

(iv)          Participant
agrees further that Participant will not improperly use or disclose any confidential information or trade secrets, if any, of any
former employers or any other Person to whom Participant has an obligation of confidentiality, and will not bring onto the premises
of the Partnership or any member of the Partnership Group any unpublished documents or any property belonging to any former employer
or any other Person to whom Participant has an obligation of confidentiality unless consented to in writing by the former employer
or other Person.

 

    

     

    

 

(b)           Nothing
in this Agreement shall prohibit or impede the Participant from communicating, cooperating or filing a complaint with any U.S.
federal, state or local governmental or law enforcement branch, agency or entity (collectively, a “Governmental Entity”)
with respect to possible violations of any U.S. federal, state or local law or regulation, or otherwise making disclosures to any
Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided
that in each case such communications and disclosures are consistent with applicable law. The Participant understands and acknowledges
that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure
of a trade secret that is made (i) in confidence to a federal, state, or local government official or to an attorney solely
for the purpose of reporting or investigating a suspected violation of law, or (ii) in a complaint or other document filed
in a lawsuit or other proceeding, if such filing is made under seal. The Participant understands and acknowledges further that
an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade
secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files
any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. Notwithstanding
the foregoing, under no circumstance will the Participant be authorized to disclose any information covered by attorney-client
privilege or attorney work product of any member of the Company without prior written consent of the Company’s General Counsel
or other officer designated by the Company.

 

(c)           Intellectual
Property.

 

(i)            Participant
agrees that the results and proceeds of Participant’s services for the Partnership Group (including, but not limited to,
any Confidential Information and other trade secrets, products, services, processes, know-how, designs, developments, innovations,
analyses, drawings, reports, techniques, formulas, methods, developmental or experimental work, improvements, discoveries, inventions,
ideas, source and object codes, programs, matters of a literary, musical, dramatic, or otherwise creative nature, writings, and
other works of authorship) resulting from services performed while an employee of the Partnership and any works in progress, whether
or not patentable or registrable under copyright or similar statutes, that were made, developed, conceived, or reduced to practice
or learned by Participant, either alone or jointly with others (collectively, “Inventions”), shall be
works-made-for-hire, and the Partnership (or, if applicable or as directed by the Partnership, any member of the Partnership Group)
shall be deemed the sole owner throughout the universe of any and all trade secret, patent, copyright, and other intellectual property
rights (collectively, “Proprietary Rights”) of whatsoever nature therein, whether or not now or hereafter
known, existing, contemplated, recognized, or developed, with the right to use the same in perpetuity in any manner the Partnership
determines in its sole discretion, without any further payment to Participant whatsoever. If, for any reason, any of such results
and proceeds shall not legally be a work-made-for-hire or there are any Proprietary Rights that do not accrue to the Partnership
(or, as the case may be, any member of the Partnership Group) under the immediately preceding sentence, then Participant hereby
irrevocably assigns and agrees to assign any and all of Participant’s right, title, and interest thereto, including any and
all Proprietary Rights of whatsoever nature therein, whether or not now or hereafter known, existing, contemplated, recognized,
or developed, to the Partnership (or, if applicable or as directed by the Partnership, any member of the Partnership Group), and
the Partnership or such member of the Partnership Group shall have the right to use the same in perpetuity throughout the universe
in any manner determined by the Partnership or such member of the Partnership Group without any further payment to Participant
whatsoever. As to any Invention that Participant is required to assign, Participant shall promptly and fully disclose to the Partnership
all information known to Participant concerning such Invention.

 

    

     

    

 

 

(ii)           Participant
agrees that, from time to time, as may be requested by the Partnership and at the Partnership’s sole cost and expense, Participant
shall do any and all things that the Partnership may reasonably deem useful or desirable to establish or document the Partnership’s
exclusive ownership throughout the United States of America or any other country of any and all Proprietary Rights in any such
Inventions, including the execution of appropriate copyright or patent applications or assignments. To the extent that Participant
has any Proprietary Rights in the Inventions that cannot be assigned in the manner described above, Participant unconditionally
and irrevocably waives the enforcement of such Proprietary Rights. This Section 2(b)(ii) is subject to and shall not
be deemed to limit, restrict, or constitute any waiver by the Partnership of ownership of any Proprietary Rights to which the
Partnership (or other applicable member of the Partnership Group) may be entitled by operation of law by virtue of the Partnership’s
(or other applicable member of the Partnership Group’s) being Participant’s employer. Participant agrees further that,
from time to time, as may be requested by the Partnership and at the Partnership’s sole cost and expense, Participant shall
assist the Partnership in every reasonable, proper and lawful way to obtain and from time to time enforce Proprietary Rights relating
to Inventions in any and all countries. To this end, Participant shall execute, verify, and deliver such documents and perform
such other acts (including appearances as a witness) as the Partnership may reasonably request for use in applying for, obtaining,
perfecting, evidencing, sustaining, and enforcing such Proprietary Rights and the assignment thereof. In addition, Participant
shall execute, verify, and deliver assignments of such Proprietary Rights to the Partnership or its designees. Participant’s
obligation to assist the Partnership with respect to Proprietary Rights relating to such Inventions in any and all countries shall
continue beyond the termination of Participant’s employment with the Service Recipient.

 

(iii)          Participant
hereby waives and quitclaims to the Partnership any and all claims, of any nature whatsoever, that Participant now or may hereafter
have for infringement of any Proprietary Rights assigned hereunder to the Partnership.

 

3.            Non-Disparagement.
Participant shall not, whether in writing (electronically or otherwise) or orally, malign, denigrate, or disparage the Partnership,
any other member of the Partnership Group, or any of their respective predecessors or successors, or any of their respective current
or former managers, directors, officers, employees, shareholders, partners, members, agents, or representatives, with respect to
any of their respective past or present activities, or otherwise publish (whether in writing (electronically or otherwise) or orally)
statements that tend to portray any of the aforementioned parties in an unfavorable light. The Partnership shall instruct its members,
the members of its board of directors, and the senior executives of the Service Recipient, in their capacities as such, not to,
whether in writing (electronically or otherwise) or orally, malign, denigrate, or disparage Participant with respect to his past
or present activities, or otherwise publish (whether in writing (electronically or otherwise) or orally) statements that tend to
portray Participant in an unfavorable light.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]